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Diabetes mellitus is a most common endocrine disorder, affecting more than 300 
million people worldwide. For this, therapies developed along the principles of western 
medicine (allopathic) are often limited in efficacy, carry the risk of adverse effects, and 
are often too costly, especially for the developing world. In order to identify 
complementary or alternative approaches to existing medications, we studied the anti-
diabetic potential of Eremurus himalaicus-An endemic plant of North-Western 
Himalayas. The acute oral toxicity studies of the extracts revealed no toxic effects up to 
the levels of 2000 mg/kg b. wt. The Ethyl Acetate, Methanol and Aqueous extracts of 
Eremurus himalaicus were screened for the presence of hypoglycaemic and antidiabetic 
activity. In this study diabetes was induced by a single IP dose Alloxan monohydrate. 
The study was carried out on a 14 day protocol and the blood glucose, SGOT, SGPT and 
ALP levels were measured on Day 0, Day 7 and Day 14 of the treatment, along with 
histopathological examination of pancreas on day 14. Maximum activity was shown by 
the ethyl acetate extract with a percent variation in blood glucose level of 30.78% and 
48.78% followed by aqueous extract with a percent variation in blood glucose level of 
25.43% and 38.77% at a dose level of 250 mg/kg b. wt. and 500 mg/kg b. wt. 
respectively. Glibenclamide was taken as the standard and the results were quite 
comparable with it. The histopathological studies also indicated that Eremurus 
himalaicus is effective in regeneration of insulin secreting β-cells and thus possesses anti-
hyperglycaemic activity. The results also showed that Eremurus himalaicus protects 
significantly from other physiological aberrations i.e., polydypsia, polyphagia, weight 
loss and metabolic aberrations i.e., increase in SGOT, SGPT, ALP, cholesterol and 
triglyceride levels caused by diabetes, in a dose dependent manner. The aqueous extract 
also showed significant effect in increasing the oral glucose tolerance of rats and it also 
showed good hypoglycaemic activity in normoglycaemic rats. The preliminary 
phytochemical analysis of the extracts of Eremurus himalaicus revealed the presence of 
alkaloids, tannins, saponins, terpenoids, flavonoids, phenolics and glycosides as the 
possible biologically active principles. 
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 Mankind has been using plant materials for treatment of his ailments since time 
immemorial. Since ancient times, before modern medicine, people became ill and 
suffered from various ailments. In the absence of modern medicinal remedies people 
relied on herbal remedies derived from plants and herbs. Medicinal plants have been used 
for centuries as remedies for human diseases because they contain components of 
therapeutic value (Nostro et al., 2000). Medicinal plants, herbs, spices and herbal 
remedies are known to Ayurveda in India since long times. History of herbal remedies is 
very old. The unani/ayurvedic drugs have stood the test of time for their safety, efficacy, 
cultural acceptability and toxicity. About 75-80% of the world population, mainly in the 
developing countries still use plant based medicines for primary health care. Plants have 
also been a significant source of the modern day drugs. Many of the currently available 
drugs were derived directly or indirectly from phytochemicals (Grover et al., 2002). 
 There are less than 1% of some 250,000 higher plants that have been screened in-
depth for their phytochemistry or pharmacology (Petlevski et al., 2001). However, herbs 
are staging a comeback and 'herbal renaissance’ is happening all over the globe. Herbal 
medicines are still being used in many countries, because of their compatibility with the 
human body, cheapness, and minimum side effects. During the last decade there has been 
a major increase in the use of medicinal plants all over the world particularly in U.S.A. 
and European countries. The World Health Organization estimated that about 80% of the 
earth's inhabitants rely on traditional medicine for their primary health care needs, which 
primarily involves the use of plant extracts or their active components. The beneficial 
medical effects of plant materials typically result from the combination of secondary 
products present in the plant; majority of these are secondary metabolites like alkaloids, 
tannins and phenolic compounds. These secondary metabolites exert their effects by 
resembling endogenous metabolites, ligands, hormones, signal transduction molecules or 
even neurotransmitters. Hence the screening of plants for such properties is an important 
step. The herbal products today symbolise safety in contrast to the synthetics that are 
regarded as unsafe to human and environment. Although herbs have been priced for their 
medicinal, flavouring and aromatic qualities for centuries, the synthetic products of the 
modern age surpasses their importance, for a while. However, the blind dependence on 
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synthetics is over and people are returning to the naturals with hope of safety and 
security. Over three-quarters of the world population nowadays relies mainly on plants 
and plant extracts for health care (Fabricant et al., 2001). 
 India has a rich heritage of usage of medicinal plants in the Ayurvedic, Siddha 
and Unani system. Many Indian plants have been investigated for their beneficial use in 
different diseases and reports occur in numerous scientific journals. The country has 
about 15000 medicinal plants that include 7000 plants used in Ayurveda, 700 in Unani, 
600 in siddha, 450 in Homeopathy and 30 in modern medicines (Das, 2008). The plant 
extracts and its product play an important role in treating many symptoms. Medicinal 
plants have been tested for biological, antimicrobial and hypoglycemic activity 
(Glombitza et al., 1994).They have been also tested for antiulcerogenic, antihelminthic, 
hepatoprotective, analgesic, antipyretic, antileishmania and insecticidal activities 
(Mahnesh et al., 1986; Nadir et al., 1986; Alkofahi et al., 1997).  
 World ethnobotanical information about medicinal plants reports almost 800 
plants used in the control of diabetes mellitus (Alarcon-Aguilara et al., 1998). During 
the 18th century, the active principles of a number of antidiabetic plant drugs were 
isolated; hence it became possible to administer these in standardized dosage forms. 
Based on a large number of chemical and pharmacological research work, numerous 
bioactive compounds have been found in medicinal plants for diabetes (Zhang et al., 
2000; Wu et al., 1992). Potential mechanism by which compounds can reduce blood 
glucose include increasing insulin action, decreasing hepatic glucose production, 
increasing peripheral glucose metabolism independently of insulin and decreasing 
nutrient ingestion etc. Some compounds such as polyphenols, lectins, fiber and phytic 
acid are negatively correlated with the glycemic index. Many of the herbal drugs used in 
diabetes also have antioxidant activity indicating that reduced oxidant state can reduce 
the extent of glucose level in the body (Hongxiang et al., 2009). A number of 
investigators have shown that cumarins, flavonoids, terpenoids, and a host of other 
secondary plant metabolites, including arginine and glutamic acid, possess hypoglycemic 
effect in various experimental models (Marles and Farnsworth, 1995; Ross, 2001). 
Many of these are being used in unani/ayurvedic system of medicine for the treatment of 
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diabetes. However, most of the species of higher plants have not been screened for 
chemical or biologically active constituents (Balandarin et al., 1985). It is a big 
challenge to fully exploit medicinal biodiversity to look for phytochemicals with insulin 
mimetic property. 
 Diabetes mellitus is a most common endocrine disorder, affecting more than 300 
million people worldwide. Diabetes mellitus is a debilitating and life threatening disease 
as long as mankind. It is a series of metabolic conditions associated with hyperglycemia 
and caused by defects in insulin secretion and/or insulin action (Bell 1991, Afifi et al 
2005, Ahmed and Goldstein, 2006, Dinneen, 2006). It is characterized by derangements 
in carbohydrate, protein and fat metabolism (Djomeni et al, 2006). Diabetes is a 
condition primarily defined by the level of hyperglycemia giving rise to risk of 
microvascular damage (retinopathy, nephropathy and neuropathy). It is associated with 
reduced life expectancy, significant morbidity due to specific diabetes related 
microvascular complications, increased risk of macrovascular complications (ischemic 
heart disease, stroke and peripheral vascular disease), and diminished quality of life. 
Diabetes mellitus is a chronic disease whose global spread has given it the characteristics 
of a pandemic. The most frequent form is Type 2 diabetes which represents more than 
85% of the cases. Other forms are Type 1 (10%), specific diabetes and gestational 
diabetes (5%) (WHO/IDF, 1999). For this, therapies developed along the principles of 
western medicine (allopathic) are often limited in efficacy, carry the risk of adverse 
effects, and are often too costly, especially for the developing world. Therefore, treating 
diabetes mellitus with plant derived compounds which are accessible and do not require 
laborious pharmaceutical synthesis seems highly attractive. Although, oral hypoglycemic 
agents and insulin is the mainstay of treatment of diabetes and are effective in controlling 
hyperglycemia, they have prominent side effects and fail to significantly alter the course 
of diabetic complications (Rang and Dale, 2011). As the knowledge of heterogeneity of 
this disorder increases, there is a need to look for more efficacious agents with lesser side 
effects. Over the years, various medicinal plants and their extracts have been reported to 
be effective in the treatment of hyperglycemia and diabetes (Marles and Farnsworth, 
1995). The hypoglycaemic actions of some of these phytochemical constituents have 
been evaluated and confirmed in animal models (Hwang et al., 2005; Vinson et al., 
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2005) suggesting that natural products could serve as a source in the search for effective 
antidiabetic agents. Indeed, the widely prescribed insulin-sensitizer metformin was 
derived from guanidine, a molecule isolated from Galega officinalis L. (Bailey and Day, 
2004; Witters, 2001). Moreover, Trigonella foenum-graecum L. (Fenugreek) is a plant 
long-consumed around the world for its anti-diabetic properties (Broca et al., 2001). 
Considering the significant importance of the antidiabetic agents from natural products 
against diabetes, development of new effective agents with fewer side effects is a 
compelling urgency. 
 Our valley of Kashmir being a rich source of medicinal plants possesses a great 
potential that could be exploited for the welfare of the mankind. More than 50% of plant 
species described in British pharmacopoeia is reported to grow in Kashmir Valley 
(Shawl, 2008). Kachroo and Nahvi (1976) have listed a total of 103 medicinal plant 
species used by early Kashmiris. Guna (2006) has reported 220 medicinal plant species, 
belonging to 178 genera distributed over 77 families used in Kashmir. There are still 
many plants which have not been paid due attention. 
 Eremurus himalaicus (Himalayan Desert Candle) is a plant that can be easily 
identified by its tall stout spike-like cluster of hundreds of white flowers with protruding 
orange anthers (Nayar and Sastry, 1987). Himalayan Desert Candle is found on rocky 
slopes of the drier areas of Himalayas, from Afghanistan to Himachal Pradesh, at 
altitudes of 2100-3300 m asl. It belongs to the family Liliaceae. In a survey conducted on 
37 plant species belonging to 33 genera and 23 angiospermic families the third most 
dominant antidiabetic plant bearing family was Liliaceae (3 spp.), thus there is a good 
chance of it possessing the antidiabetic activity (Ahmad et al., 2009). Pankaj Oudhia, a 
famous agriculture scientist (an internationally acknowledged herb expert engaged in 
allelopathic research) in his report titled "Traditional medicinal knowledge about herbs 
and herbal combinations used in treatment of Type II diabetes in India with special 
reference to Chhattisgarh" has reported Eremurus himalaicus being used in the 
management and prevention of diabetes (Oudhia, 2008). Thus further validation may 
lead to the discovery of a new drug in the management of diabetes.  
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 Being endemic to Kashmir the plant stands a good chance for its inclusion among 
the medicinal plants of the valley. Till date no work has been reported on the anti-diabetic 
medicinal value of   Eremurus himalaicus. Therefore, the present study is the first attempt 
to assess the potential anti-diabetic activity of Eremurus himalaicus. 
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“The art of medicine consists of amusing the patient while Nature cures the disease.” 
-Voltaire  
 2.1 Herbal remedies in general 
 Ethnopharmacology is the study of plants used in traditional medicine and is 
therefore heavily reliant on interactions between researchers and indigenous communities 
who passed on the traditional knowledge over generations. Whilst in the main, 
ethnopharmacology focuses on the presence or absence of evidence for specific 
therapeutic responses through the use of herbal remedies, the field also extends into 
phytochemistry where the aim is to identify the chemical constituent of the plant or plant 
extract that is responsible for the pharmacological activities inherent to a specific plant.  
Ethnopharmacology may be best described as the multidisciplinary science aimed at 
studying herbal remedies (Mulholland, 2005).  There are four major types of herbal 
medicines in existence today according to Elvin-Lewis (2001); Asian, European, 
Indigenous African Medicines and Neo-western. The Asian herbal medicinal system has 
its origins in India, China, and Japan with the Ayurvedic, Unani and Siddha practice from 
India, WuHsing from China and Kampo from Japan (Feng et al., 2006). Asian and 
African indigenous herbal systems are the most diverse forms of medicines and still 
practiced by various cultures where they are still intact. European herbalism has its roots 
in the Mediterranean civilization and has since evolved to include plants from all over the 
world. Neo-western herbal medicine is the latest branch in the herbal industry and 
constitutes a combination of the European medicinal system and indigenous African 
herbal systems (Feng et al., 2006). 
 
2.2 Herbalism in India 
 In the last few years there has been an exponential growth in the field of herbal 
medicine and these drugs are gaining popularity both in developing and developed 
countries because of their natural origin and less side effects. Many traditional medicines 
in use are derived from medicinal plants, minerals and organic matter.  A number of 
medicinal plants, traditionally used for over 1000 years named Rasayana/Unani are 
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present in herbal preparations of Indian traditional health care systems.  In Indian systems 
of medicine most practitioners formulate and dispense their own recipes (Sangeeta et al., 
2011). The World Health Organization (WHO) has listed 21,000 plants, which are used 
for medicinal purposes around the world. Among these 2500 species are in India, out of 
which 150 species are used commercially on a fairly large scale. India is the largest 
producer of medicinal herbs and is called as botanical garden of the world (Maurya et 
al., 2011). Therefore, with the rising number of diseases lately, many researchers have 
evaluated the medicinal plants as alternative therapeutic agents. The effectiveness and 
safety of drugs derived from the medicinal plants require scientific evaluation to establish 
the profiles of therapeutic effectiveness and toxicity of plant products. One example of 
such products is antihyperglycemic agents for use in the treatment of diabetes mellitus. 
 
2.3 Diabetes 
2.3.1 Introduction 
The first recorded description of diabetes mellitus dates back to the Ebers papyrus 
in Egypt around 1500 BC and it has also been noted in almost all of the ancient culture 
from Asia to Europe to the Americas (Soumyanath, 2005). The term diabetes mellitus 
describes a metabolic disorder of multiple etiologies characterized by chronic 
hyperglycaemia with disturbance of carbohydrates, fat and protein metabolism (Alberti 
et al., 1998). Diabetes is a chronic disease that occurs when the pancreas fails to produce 
sufficient insulin, or when the body cannot effectively use the insulin it produces. Since 
insulin is the main hormone that regulates blood glucose levels, hyperglycaemia is a 
common result of uncontrolled diabetes, which over time can lead to serious damage to 
many of the body's systems especially the nerves and blood vessels (WHO, 2006; 
Simeon et al., 1991). A chronic hyperglycemic condition in diabetes is associated with 
long term damage, dysfunction, and failure of various organs, such as eyes, kidneys, 
nerves, heart, and blood vessels (Jadhav and Puchchakayala, 2012). 
 The term diabetes has been derived from the Greek word "diabainein" meaning 
"to pass through". Thomas Willis observed that the urine of a diabetic patient was sweet 
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and he surmised that it contained either sugar or honey. In 1675, he added the name 
"mellitus" which means "sweetened with honey" in Latin and then it was proved by 
Matthew Dodsen that the sweetness in urine is due to the excessive presence of sugar in 
blood of the people with diabetes (Dallas, 2011 and Leonid, 2009). Diabetes is a 
predominant public health concern and its prevalence is rising all over the world due to 
population growth, aging, urbanization and an increase of obesity and physical inactivity 
(Ramachandran et al., 2010; Honeycutt et al., 2003; Zimmet et al., 2003). The disease 
causes substantial morbidity, mortality and long-term complications and remains an 
important risk factor for cardiovascular disease. With increasing rates of childhood and 
adult obesity, diabetes is likely to become even more prevalent over the coming decade. 
Diabetes mellitus with retinopathic, neuropathic or nephropathic complications is a 
common debilitating and often life-threatening disease that constitutes a significant risk 
factor in atherosclerosis. It is well known that diabetes mellitus is associated with an 
increased production of reactive oxygen species and a reduction in antioxidative 
defenses. The diabetic induced oxidative stress is pathogenetically important in diabetic 
complications (Naito, 2004). 
 Diabetes mellitus is a chronic disease whose global spread has given it the 
pandemic characteristics (WHO/IDF, 1999). It is the most common serious metabolic 
disorder and is considered to be one of the most leading causes of death in the world 
(Jadhav et al., 2012). The prevalence for all age-groups worldwide was estimated to be 
2.8% in 2000 and 4.4% in 2030 (IDF, 2007). Globally, as of 2010, an estimated 285 
million people had diabetes (Melmed et al., 2011). Its incidence is increasing rapidly, 
and by 2030, this number is estimated to almost double (Wild et al., 2004). Diabetes 
mellitus occurs throughout the world, but is more common in the more developed 
countries. The greatest increase in prevalence is, however, expected to occur in Asia and 
Africa, where most patients will probably be found by 2030 (Wild et al., 2004). The 
increase in incidence in developing countries follows the trend of urbanization and 
lifestyle changes, perhaps most importantly a "Western-style" diet. This has suggested an 
environmental (i.e., dietary) effect, but there is little understanding of the mechanism(s) 
at present, though there is much speculation, some of it most compellingly presented 
(Wild et al., 2004). It is the sixth leading cause of deaths worldwide (Gojka and Nigel, 
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2010). The most frequent form is type II diabetes which represents more than 85% of the 
cases. Type I account for 10% and specific and gestational diabetes accounts for about 
5% (WHO/IDF, 1999). 
 Diabetes is a quite alarming disease spreading in the developing countries 
including India. In India more than 40.9 million people have diabetes; representing 20% 
of the world‟s adult population, with numbers increasing fast everywhere. An additional 
seven million people develop the disease each year. With the spread of fast-food outlets 
and more sedentary lifestyles, the prevalence of diabetes in India is rising alarmingly. But 
the subpopulations at risk and the symptoms of the disease differ from those in the West. 
India, the world‟s second most populous country, now has more people with type 2 
diabetes (more than 50 million) than any other nation (Shaw et al., 2010; Magliano et 
al., 2010; Jowett et al., 2009; Ramachandran et al., 2010; Mohan et al., 2010; 
Pradeepa et al., 2010; Sarkar, 2011).  In 2010, the average age-adjusted prevalence of 
diabetes in India was 8%, higher than that in most European countries (Shaw et al., 
2010). By contrast, surveys in 1938 and 1959, in large Indian cities that are today 
diabetes strongholds, yielded prevalence of just 1% or less. Only in the 1980s did those 
numbers start to rise, first slowly and now explosively (Mohan et al., 2010; Pradeepa et 
al., 2010). In India, a wide range of outcomes for different groups (Mohan et al., 2007; 
Mohan et al., 2008) is buried within the average diabetes prevalence of 8%. Prevalence 
is only 0.7% for non-obese, physically active, rural Indians. It reaches 11% for obese, 
sedentary, urban Indians; and it peaks at 20% in the Ernakulam district of Kerala, one of 
India‟s most urbanized states. In 2004, the prevalence of diabetes averaged 16% in urban 
India and only 3% in rural India (Mohan et al., 2008). That urban concentration of 
diabetes has also been reported in many other Asian countries. Nearly 25% of Indian city 
dwellers (the subpopulation most at risk) haven't even heard of diabetes (Mohan et al., 
2007). In Britain, the prevalence of type 2 diabetes is 14 times higher in Asian than 
European children. And although obesity is a risk factor for diabetes both in India and in 
the West, the disease appears at a lower threshold of obesity in India, as is also the case in 
China, Japan and other Asian countries (Mohan et al., 2008). Symptoms also differ 
between Indians and Westerners: Indians with diabetes are less likely to develop 
Chapter 2 
 
 Page 10 
 
blindness and kidney disease, but much more likely to suffer coronary artery disease at a 
relatively young age (Mohan et al., 2007 and Unnikrishnan et al., 2007). 
Healthcare expenditures on diabetes were expected to account for 11.6% of the 
total healthcare expenditure in the world in 2010. Estimated global healthcare 
expenditures to treat and prevent diabetes and its complications were expected to total at 
least 376 billion U.S. Dollars (USD) in 2010. By 2030, this number is projected to exceed 
some USD 490 billion (IDF, 2009). The “Top 10” countries in the world, in terms of the 
number of people with diabetes, for 2010 are India, China, Russian Federation, U.S., 
Brazil, Germany, Pakistan, Japan, Indonesia and Mexico and for 2030 are India, China, 
U.S., Pakistan, Brazil, Indonesia, Mexico, Bangladesh, Russian Federation and Egypt. At 
both time points, the three countries with the largest number of people with diabetes are 
India, China and the U.S. (IDF, 2009). This picture is likely to change soon, in light of 
the recent escalation in prevalence of diabetes (92.4 million adults) in China (Yang et al., 
2010). Roughly 80% of people with diabetes are in developing countries, of which India 
and China share the larger contribution (Ramachandran et al., 2010). Table 1 enlists the 
top ten countries for estimated numbers of adults with diabetes for the year 2010 and 
2030 (IDF, 2009). 
 
2.3.2 Classification of diabetes mellitus 
 The first widely accepted classification of diabetes mellitus was published by 
WHO in 1980 and modified in 1985 (Alberti et al., 1998). An expert committee 
proposed two major classes of diabetes mellitus and named them insulin dependent 
diabetes mellitus (IDDM) or type I and non-insulin dependent diabetes mellitus 
(NIDDM) or type II. A new class of malnutrition-related diabetes mellitus (MRDM) was 
introduced including other types like impaired glucose tolerance and gestational diabetes 
mellitus (GDM) (Alberti et al., 1998). The proposed classification encompasses both 
clinical stages and etiological types of diabetes mellitus and other categories of 
hyperglycaemia. The clinical stages reflect that diabetes, regardless of its etiology, 
progresses through several clinical stages during its natural history. People who have or 
who are developing diabetes mellitus can be categorized by a stage according to the 
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clinical characteristics, even in the absence of information concerning the etiology 
(Alberti et al., 1998).  
Diabetes mellitus is best classified into four major disease syndromes: 
1. Type I diabetes: Previously known as insulin-dependent or childhood-onset, is 
characterized by a lack of insulin production. It indicates the processes of beta-cell (β-
cell) destruction that may ultimately lead to full diabetes where exogenous insulin is 
required to prevent the development of ketoacidosis, coma and death. It is usually 
characterized by the presence of anti-glutamic acid decarboxylase (anti-GAD), islet cell 
or insulin antibodies which point to the autoimmune processes that led to beta-cell 
destruction (Alberti et al., 1998). Without daily administration of insulin, Type I diabetes 
is rapidly fatal. Symptoms include excessive urine production (polyuria), thirst 
(polydipsia), constant hunger despite patients having a voracious appetite (polyphagia), 
weight loss, vision changes and fatigue (WHO, 2006). There are no clear symptoms of 
diabetes and many people may not even know they are suffering from the disease until it 
is too late. 
2. Type II diabetes: Formerly called non-insulin-dependent or maturity/adult-onset 
diabetes (WHO, 2006). Type 2 DM is a chronic and progressive syndrome characterized 
by metabolic abnormalities such as insulin resistance and decreased pancreatic β-cell 
function that modifies fuel-sensing processes in the body (Puchchakayala et al., 2012). 
It is the most common form of diabetes and is characterized by disorders of insulin action 
and insulin secretion and either one can be the predominant feature (Alberti et al., 1998). 
Type II diabetes mellitus is more common than that of type I (Drury and Wendy, 2004). 
Type II diabetes comprises 90% of the cases of diabetes in people around the world, and 
it is largely the result of excessive body weight and physical inactivity. Symptoms may 
be similar to those of Type I diabetes, but are often less marked. As a result, the disease 
tends to go undiagnosed for several years, until severe complications have already arisen. 
Until recently, this type of diabetes was seen only in adults but it is now worryingly also 
occurring in obese children due to the lack of physical activity and an increase intake of 
high sugar diets (WHO, 2006).  
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 Type II Diabetes is characterized by fasting and postprandial hyperglycemia and 
relative insulin insufficiency. If left untreated, hyperglycaemia may cause long-term 
microvascular and macrovascular complications, such as nephropathy, neuropathy, 
retinopathy and atherosclerosis (Jain and Saraf, 2008; Ramachandran et al., 2011). In 
the early stages of the disease, insulin resistance in the peripheral tissues like the muscle 
and fat is associated with a compensatory increase in insulin production by pancreatic β-
cells. This increase in secretion of insulin initially promotes glucose utilization in the 
peripheral tissues and decreases hepatic gluconeogenesis. Unfortunately fasting insulin 
levels progressively increase in a step-wise manner until the β-cells can no longer 
compensate for the increased insulin resistance and subsequently fail viz. it is the 
combination of β-cell failure and associated loss of insulin that eventually promotes the 
severe hyperglycaemia evident in these patients (Jain and Saraf, 2008).  
 Treatment of a type-II diabetic patient may be simple i.e. increased physical 
activity to reduce weight (and consequently insulin resistance), reduce intake of dietary 
fat and adequate intake of complex carbohydrates and fibre which improves insulin 
action and secretion or more complex through medical intervention i.e. several 
commercially available pharmaceuticals that either enhance insulin action or its secretion. 
Of the two, the first treatment option is the most beneficial as drug therapy may be 
associated with the long term underlying and undesired effects like weight gain or 
hypoglycaemia (Jain and Saraf, 2008).  
 Type I and type II diabetes were clearly thought to represent genetically 
independent diseases but various lines of evidence suggest that there is a stronger genetic 
component in the etiology of type II diabetes (Creutzfeldt and Lefebvre, 1988). It is 
known that environmental factors play a part in the manifestation of the disease as well 
(Van Tilburg et al., 2008). 
3. Type III or Gestational diabetes: This type of diabetes first occurs during pregnancy. 
During pregnancy the need for insulin appears to increase and gestational diabetes occurs 
at the late stages of pregnancy. This type of diabetes may go away once the baby has 
been born but type II diabetes may develop later in life, in woman who has had 
gestational diabetes. 
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4. Secondary diabetes: Diabetes may develop as a consequence of other diseases or 
medication. Davidson (1991) listed some causes of secondary diabetes, a term coined by 
Davidson (1991) as “other types” of diabetes, these include pancreatic diseases 
(pancreatitis, surgery, cystic fibrosis), the use of other drugs not prescribed for the 
condition (contraceptive pills, diuretics, steroids), genetic syndromes (extremely rare but 
many have been described) and endocrine diseases (Cushing‟s, Acromegaly) (Davidson, 
1991). 
5. Other Forms: The other types of diabetes (some are not true diabetes, but may 
progress into diabetes with time) arise as a result of complications and are very 
uncommon forms of diabetes mellitus, but their underlying defects and disease process 
can be identified in a relatively specific manner and include genetic defects of the beta-
cell, diseases of the exocrine pancreas, endocrinopathies, drug or chemically induced 
diabetes and uncommon forms of immune-mediated diabetes (WHO, 2002). 
 
2.3.3 Factors influencing the prevalence of diabetes 
The predisposing factors associated with diabetes mellitus are modifiable and non 
modifiable factors. The modifiable risk factors which are associated with type II diabetes 
include consumption of foods that are rich in energy and fat; and low in fiber diet, obesity 
and decreased physical activity. The non modifiable risk factors of type 2 diabetes are 
age and ethnicity (Shaw and Chrisholm, 2003; Wild et al., 2004). Genetic 
predisposition is also associated with the development of diabetes mellitus .On the other 
hand, people without any family history of the disease can also develop diabetes putting 
the genetic basis of the disease in question (ADA, 2004). Many risk factors have been 
identified which influence the prevalence or incidence of diabetes type II (Van Tilburg 
et al., 2008). Factors of particular importance are: 
• Age: Age is the single most important variable influencing the prevalence of diabetes.  
Epidemiological studies show that prevalence increases with ages above 40. Oddly there 
has also been recorded evidence of declining incidence with old age in some countries in 
Europe and the America (Jain and Saraf, 2008; Ikram et al., 2011). 
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• Gender: While diabetes was believed to be more common in females than males, recent 
trends have shown an equal prevalence for both males and females. However, there may 
be an increase in the prevalence of the disease in men in the last decade (Jain and Saraf, 
2008). 
• Country and place of residence: While there appears to a country-associated 
distribution of the disease, this is most likely skewed due to the population age i.e. due to 
the fact that diabetes is an age related disorder; countries with elderly populations have 
more cases of diabetes compared to developing countries with younger populations. In 
some traditional communities in developing countries diabetes is rare. Diabetes is 
considered as a disease of urbanization and several studies have found that the prevalence 
is significantly higher in urban populations than in rural communities within the same 
country (Jain and Saraf, 2008). 
• Ethnicity: Many studies have shown the impact of ethnicity on the prevalence of 
diabetes e.g. studies have shown that Mexican Americans have a 1.9 times higher 
prevalence of diabetes than Native Americans. A locally based study showed that 
diabetes was 4 times higher in Indian men than white men and twice as high in Indian 
women than white women (Jain and Saraf, 2008). When the traditional lifestyle among 
blacks was followed in the past, diabetes was virtually absent. Since the 1960s studies in 
South Africa indicated that the majority of the diabetic cases were all entirely hospital 
based. A study conducted in Cape Town showed a prevalence rate of 3% in 1969 of the 
black community, since then WHO has indicated an increase of up to 8% in 1985 
(Bourne et al., 2002). Currently in South Africa the prevalence rate has risen to almost 
30% of the population due to urbanization (Bourne et al., 2002). 
• Socio-economic status and lifestyle: Socio-economic deprivation associated with poor 
diet (unhealthy diets- high calorific / saturated fats) and other adverse lifestyle factors are 
linked to high rates for diabetes (Jain and Saraf, 2008; Ikram et al., 2011). 
• Obesity: It is clear that obesity is a risk factor associated with diabetes type II diabetes 
as the prevalence of both obesity and diabetes have grown concurrently in many 
developing and developed countries (Ikram et al., 2011). 
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2.3.4 Diagnosis of diabetes mellitus 
The criteria for the diagnosis of diabetes are shown in Table 1. Three ways to 
diagnose diabetes are possible, and each, in the absence of unequivocal hyperglycemia, 
must be confirmed, on a subsequent day, by any one of the three criteria given (ADA, 
2008). 
 
Table 1: Criteria for the diagnosis of diabetes 
Criterion 1  
 
 
 
Or 
Criterion 2  
 
 
 
Or 
Criterion 3 
 
Symptoms of diabetes 
and casual plasma 
glucose 200 mg/dl 
(11.1mmol/l). 
 
 
Casual is defined as: Any time of 
day without regard to time since 
last meal. The classic symptoms of 
diabetes include: Polyuria, 
polydypsia, and unexplained 
weight loss. 
 
FPG 126 mg/dl 
(7.0mmol/l). 
 
 
 
Fasting is defined as no caloric 
intake for at least 8 h. 
 
 
2 hour plasma 
glucose 200 mg/dl 
(11.1mmol/l) 
during an OGTT.  
 
 
The test should be performed 
as described by the World 
Health Organization, using a 
glucose load containing the 
equivalent of 75 g anhydrous 
glucose dissolved in water. 
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2.3.5 Treatment 
2.3.5.1 Insulin therapy 
The main treatment of type I and more severe forms of type II diabetes mellitus is 
still dependent on insulin treatment. At present a number of different formulations of 
insulin are available for use in people. The differences are due to dose, source (animal or 
transgenic), purity and type (based on formulation) (rapid acting type e.g. “Toronto” 
insulin and slow/intermediate type e.g. protamine zinc insulin) (Krall and Beaser, 1989). 
In addition from a clinical perspective, the formulation may be characterised by the onset 
of action (how quickly it works), time of peak activity (time to best effect) and duration 
of action. Irrespective of the type of insulin in use, the aim of insulin therapy for patients 
with type I diabetes is to achieve normal glycaemia levels with minimal 
pathophysiological side effects (Davidson, 1991). While the advent of modern insulin 
formulations has changed the lives of many diabetic sufferers for the better, this has come 
with the occurrence of numerous adverse drug reactions: 
• Delayed local reaction at site of injection (Davidson, 1991). 
• Insulin allergy (Davidson, 1991). 
• Insulin resistance (Davidson, 1991). 
• Insulin induced lipoatrophy (Davidson, 1991).  
• Insulin induced lipohypertrophy (Davidson, 1991). 
 
2.3.5.2 Other forms of diabetic therapies 
Other treatments available for use have become known as the oral hypoglycaemic 
as they can be administered orally unlike parenteral insulin. As the name implies, the oral 
hypoglycaemic agents work by lowering the glucose levels in the blood. There are 
several antidiabetic medications available and their use depends on the nature of the 
diabetes, age, situation of the person and several other factors.  
The most common forms of type II diabetic drugs are:  
Chapter 2 
 
 Page 17 
 
• Sulphonylurea e.g. glibenclamide, are established oral hypoglycaemic agents that act 
by stimulating insulin secretion by the pancreatic β-cells. These drugs effectively reduce 
blood glucose levels in type II diabetic patients in the short term. These drugs have, 
however, not proved to be of much benefit in reducing the long term complications of the 
disease and at times may be associated with increased weight gains which may eventually 
lead to hypertension (Hanefeld, 1998). 
• Metformin is a relatively old antidiabetic drug that improves the peripheral insulin 
effect at the musculature and inhibits hepatic gluconeogenesis by enhancing the uptake of 
glucose into the peripheral cells. It does have a number of undesired side effects such as 
hepatic impairment, renal impairment and heart failure and it has an anorexic effect 
(Hanefeld, 1998).  
• Acarbose is a novel antidiabetic drug that attenuates postprandial hyperglycemia by 
delaying carbohydrate digestion, without causing major side effects. Acarbose exerts its 
inhibitory effects on the alpha-glucosidases, a family of membrane bound enzymes in the 
intestine that are involved in the digestion and uptake of carbohydrate into the blood 
stream. Acarbose initiates a cascade of events which leads to improved metabolic control 
in type II diabetes of all stages, by stimulating both the synthesis and secretion of insulin 
and in addition improves glycemic control when administered concurrently with other 
antidiabetic agents. The most common side effect reported of acarbose therapy is 
meteorism and flatulence. There are rare cases of patients experiencing diarrhoea 
resulting from the bacterial fermentation in the colon (Hanefeld, 1998). 
• Other therapies with a yet to be identified mechanism of effect are the plant extracts 
currently in use for the treatment and control both diabetes type I and 2 e.g. Sutherlandia 
frutescens, H. hemerocallidea and Psidium guajava etc. 
 
2.3.5.3 Concurrent non-drug therapy 
In addition to drug therapy, a proper diet is critical in the therapy of diabetes 
mellitus. Such diets should be balanced and nutritious, ensuring normal growth and 
development and the attainment of the ideal body weight. When these diets are 
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formulated, the total caloric intake of the patient is designed specifically for the ideal 
weight of the patient. In addition these diets are designed so that the total caloric intake is 
divided between the categories of carbohydrates, protein and fat with the use of natural 
foods high in fiber being highly encouraged (McDowell et al., 2007). Exercise in type II 
DM patients is usually beneficial as it is increases total energy expenditure, which when 
combined with a healthy diet, should assist in weight loss. Regular exercise also helps to 
maintain lean body mass (McDowell et al., 2007). However, in insulin dependent 
diabetic patients exercise may cause hypoglycaemia due to increased absorption of 
insulin from the injection site and enhanced effectiveness at the tissue level (Davidson, 
1991). 
 
2.4 Herbal remedies and diabetes mellitus 
Despite lifestyle modification as first-line approach for early stage diabetic patients, type 
2 DM treatment through drug prescription remains to be the major successfully approach 
to improve this condition. Thus, there are several classes of approved oral antidiabetic 
drugs. However, most of them exert undesirable side effects, drug interactions and the 
treatment is expensive since antidiabetic therapies comprise polypharmacy regimen. 
Diabetes mellitus has been identified by the Indian Council of Medical Research as one 
of the refractory diseases for which satisfactory treatment is not available and suitable 
herbal preparations need to be investigated (Maniyar and Bhixavatimath, 2012). 
Natural products and their derivatives have been a successful source of bioactive 
molecules in medicines much before the advancement of other modern therapeutics in the 
post-genomic era (Puchchakayala et al., 2012). Medicinal plants have been used 
virtually in all cultures as a source of medicine (Sofowora, 1996).  
The use of medicinal plants for treatment of diabetes mellitus dates back from the 
Ebres papyrus about 1550 B.C (Kesari et al., 2005; Gupta et al., 2005). Before the 
introduction of insulin and other pharmaceutical preparations traditional medicine mainly 
derived from plants were used to treat diabetes mellitus. Uses of herbs has been practiced 
for centuries in all parts of the world in different systems of medicine like Ayruveda, 
Siddha ,Unani, Naturopathy and others (Kameswara Rao and Appa Rao, 2001). The 
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use of herbal remedies and plant derivatives has gathered a lot of interest since the 1980s 
and the use of complementary and alternative medicine has grown in many countries 
around the world. Studies conducted in several developed countries such as Australia, 
United Kingdom and United States of America report that almost half to two thirds of the 
population affected with diabetes use complementary and alternative medicine to control 
the condition (Ceylen et al., 2008). The world health organization has recommended and 
encouraged the use of alternative therapy especially in countries where access to the 
conventional treatment of diabetes is not adequate (WHO, 1980).  
 Effective blood glucose control is the key to preventing or reversing diabetic 
complications and improving quality of life in patients with diabetes (De Fronzo et al., 
1999). There are many synthetic antidiabetic agents currently available; however, these 
have a number of adverse effects on the body (Jung et al., 2006; Mondal et al., 2012). 
Therefore, managing diabetes without any side effects is still a challenging task for health 
care providers. Currently available therapies for diabetes include insulin and various oral 
antidiabetic agents such as sulfonylureas, biguanides, α-glucosidase inhibitors, and 
glinides, which are used as monotherapy or in combination to achieve better glycemic 
regulation. Many of these oral antidiabetic agents have a number of serious adverse 
effects, thus managing diabetes without any side effects is still a challenge (Saxena et al., 
2004). The treatment of diabetes with synthetic drugs is costly and chances of side effects 
are high. For example, long-term use of Exenetide has lead to side effects such as nausea, 
vomiting, diarrhea, dizziness, headache, jittery feeling and acidity. Sulfonylureas cause 
abdominal upset, headache and hypersensitivity, while Metformin causes diarrhea, 
nausea, gas, weakness, indigestion, abdominal discomfort and headache (Bolen et al., 
2007). Thiazolidinediones have side effects like, upper respiratory infections and 
sinusitis, headache, mild anemia, retention of fluid in the body which may lead to heart 
failure and muscle pain. In 2007, a meta-analysis of controlled clinical trials found 
increase in the risk of myocardial infarction and a near-significant increased risk of death 
from cardiovascular causes when rosiglitazone was compared with placebo or with 
standard diabetes drugs (Lee et al., 2002). In July 2010, the Health Ministry of India 
ordered Glaxo Smith Kline to suspend human studies being conducted in 19 sites across 
India. Subsequently, in October 2010, the Drug Controller General of India (DCGI) 
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proposed to the Health Ministry to ban rosiglitazone, a well known antidiabetic drug 
(Nissen et al., 2007). Pioglitazone affects a diverse array of metabolic and inflammatory 
processes potentially relevant to cardio vascular disease pathophysiology, including key 
metabolic risk factors (dyslipidemia, hyperglycemia, and hypertension), insulin 
resistance, endothelial dysfunction and inflammatory cytokines, markers of plaque 
stability, adhesion molecules, and mediators of coagulation/fibrinolysis 
(www.indianexpress.com). Therefore, the search for more effective and safer 
hypoglycemic agents has continued to be an important area of investigation. The 
pharmacological agents with the greatest effect on postprandial hyperglycemia include 
insulin, lispro, amylin analogues, and α-glucosidase inhibitors. In hyperglycemia 
associated with diabetes, the use of aldose reductase inhibitors has been reported for the 
treatment of diabetic complications (Erdmann et al., 2010). 
The conventional pharmacological treatments for diabetes have a number of 
limitations, such as adverse effects and high rates of secondary failure. However, 
medicinal herbs are expected to have a similar degree of efficacy without the troublesome 
side effects associated with conventional drug treatment. Presently, there is growing 
interest in herbal remedies due to the side effects associated with the oral hypoglycemic 
agents (therapeutic agent) for the treatment of diabetes mellitus (Kako et al., 1997; 
Shruthi et al., 2012). Many natural components participate in a variety of antidiabetic 
functions in vivo (Kato et al., 1995; Miura et al., 2005). The use of medicinal plants has 
flourished as an alternative for the treatment of diabetes because modern medicines are 
tagged with several side effects and are also expensive. A multitude of herbs and 
medicinal plants and some compounds purified from them have been studied for the 
treatment of diabetes throughout the world as they might provide a basis of new synthetic 
antidiabetic analogues with potent activity (Grover et al., 2000). Indeed, the widely 
prescribed insulin-sensitizer metformin was derived from guanidine, a molecule isolated 
from Galega officinalis L. (French lilac) (Witters 2001; Bailey and Day, 2004). Plants 
which have been shown to have hypoglycemic action, act on blood glucose through 
different mechanisms. Some of them may inhibit endogenous glucose production 
(Eddouks et al., 2003) or interfere with gastrointestinal glucose absorption 
(Musabayane et al., 2006) some may have insulin-like substances (Collier et al., 1987). 
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Various plants have been screened for their hypoglycemic property and some of the 
plants were tested as traditional usage indicated their potential for use as antidiabetic 
agent, while the other plants were studied for experiments with plant species classified 
under the same family or genus which showed blood glucose lowering activity 
(Chattopadhyay et al., 1998). There has been a lot of success with the use of plant 
species to treat and control diabetes and its complications. The hypoglycemic effect of 
several plants used as antidiabetic remedies has been confirmed, and the mechanisms of 
hypoglycemic activity of these plants are being studied (Mankil et al., 2006). 
 Although there has been a lot of speech regarding this field, however, only a small 
number of these plants has been studied to evaluate the effect of the herbal therapies on 
the diabetic condition in-vivo. In many of the studied cases, it has been observed and 
documented that the plants under study have the ability to regulate or contribute to the 
regulation and production of insulin and glucose absorption to a great degree (Ceylan et 
al., 2008). The use of herbal remedies and plant derivatives to help in the treatment of 
diabetes should certainly not be discounted. Although numerous „miracle herbal cure‟ 
companies exist, and champion the ability of herbal compounds to supplement insulin as 
a treatment, these should not be taken at face value without thorough research (Ceylan et 
al., 2008). In India a number of plants are mentioned in ancient literature (Ayurveda) for 
the cure of diabetic conditions known as „madhumeha‟ and some of them have been 
experimentally evaluated and the active principles isolated. However, search for new 
anti-diabetic drugs continues (Shruthi et al., 2012). The herbal remedies for diabetes 
have been very helpful in the treatment of this disease; however, these also come with 
some limitations. A brief overview of some of the important and more common plants 
that have been researched upon is given below with their pros as well as cons. 
Raw onion bulbs (Allium cepa) and garlic cloves (Allium sativum) have long been used as 
dietary supplements for the traditional treatment of diabetes in Asia, Europe, and the 
Middle East (Day, 1984). Concentrated extracts from the plant organs exerted weak 
hypoglycemic effect in healthy and alloxan-induced diabetic animals and healthy humans 
(Jain et al., 1973; Augusti and Benaim 1975; Jain and Vyas 1974; Day and Bailey, 
1986; Raman et al., 2012). The fasting glucose concentrations were lowered and oral 
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glucose tolerance was improved by 7-18% within 1-2 h after oral administration of 
aqueous and ethanolic extracts of onion and garlic at doses of —10 g extract/kg body wt. 
This effect has been attributed to the volatile oils allylpropyldisulfide and diallyldisulfide 
oxide, excessive amounts of which can have detrimental effects on hepatic metabolism 
(Augusti and Benaim, 1975; Augusti, 1974). Allium species are not effective in 
pancreatectomized or severely streptozocin-induced diabetic animals, and an insulin-
releasing effect is unlikely, leaving open speculation that disulfides might retard insulin 
degradation or facilitate insulin action (Augusti and Benaim, 1975; Day and Bailey, 
1986; Swanston et al., 1989; Brahmachari et al., 1961). The claim that diphenylamine 
is a hypoglycemic principle in onion has not been substantiated (Day and Bailey, 1986; 
Karawya et al., 1984). Several plants are deemed to contain hypoglycemic alkaloids. 
Leaf infusions and decoctions of Catharanthus roseus (periwinkle) are widely used as a 
traditional treatment for NIDDM. (An infusion is prepared by submerging the plant or 
plant organ in either cold or boiling water and allowing standing. A decoction is prepared 
by submerging the plant or plant organ in cold water which is then boiled and simmered. 
After heat is withdrawn, the material is allowed to infuse.) Chronic administration of 
aqueous leaf extracts did not affect glucose homeostasis in healthy and streptozocin-
induced diabetic mice (Swanston et al., 1989). However, many major alkaloids isolated 
from this plant, including leurosine, vindoline, vindolinine, and catharanthine, exhibited a 
mild hypoglycemic effect within 2-5 h in healthy rats, but none was sufficiently potent to 
encourage further investigation (Famsworth et al., 1971; Peters et al., 1957). Further 
deterrents were the cytotoxic and neurological effects of Catharanthus alkaloids and the 
increased risk of infection, which appear to have been unappreciated or disregarded by 
traditional users of the plant. 
Seeds of Lupinus termis (lupin) used by Yemenite Jews have been reported to yield a 
fraction rich in quinolizidine alkaloids, which exerted a brief glucose-lowering effect in 
alloxan-induced diabetic rats but not healthy rats (Shani et al., 1974).  
Traditional use of leaves from Tecoma stans for the treatment of NIDDM patients has 
been supported by the isolation of two hypoglycemic alkaloids, tecomine and tecostanine. 
These alkaloids exerted a rapid (within 2 h) hypoglycemic effect when administered 
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intravenously to healthy and alloxan-induced diabetic rabbits but were ineffective in 
pancreatectomized rabbits (Hammouda and Amer, 1966; Hammouda and 
Khallafallah, 1971). The alkaloids showed poor stability and were required in 
sufficiently large doses to question their clinical potential. 
The seeds of Trigonella foenumgraecum (fenugreek) are more widely recommended for 
NIDDM patients. These seeds exerted a modest and transient hypoglycemic effect in 
several studies with healthy and mildly diabetic animals but were not effective in 
severely diabetic animals (Swanston et al., 2010; Shani et al., 1974; Mishinsky et al., 
1967; Ribes et al., 1984; Ajabnoor and Tilmisany, 1988). The hypoglycemic activity 
has been attributed to an uncharacterized alkaloid termed trigonelline, although other 
possible hypoglycemic agents such as nicotinic acid have been isolated from the seeds 
(Shani et al., 1974; Mishinsky et al., 1967). There is no evidence that fenugreek seeds 
increase insulin secretion, but chronic administration of a defatted fraction of the seeds 
reduced glucagon and somatostatin concentrations in healthy dogs (Swanston et al., 
2010; Ribes et al., 1984; Ajabnoor and Tilmisany, 1988). The high fiber content of the 
seeds (50-60%) might also contribute to a beneficial effect in diabetic patients (Madar et 
al., 1988). 
The antihyperglycemic effect of Coccinia indica (ivy gourd) has been demonstrated in a 
double-blind trial with NIDDM patients (Azad Khan et al., 1980). Consumption of 6 
tablets/day (dose unspecified) prepared from the homogenized and freeze-dried leaves of 
C. indica decreased basal glucose concentrations by -20% and similarly improved oral 
glucose tolerance after 6 wk. Aqueous and ethanolic root extracts of C. indica decreased 
glucose concentrations by >50% when administered to healthy rabbits at a dose of 1.25 
g/kg, and an uncharacterized alkaloid has been implicated as an active principle 
(Brahmachari et al., 1963). 
Cultivated fruits of Momordica charantia (karela) are widely used to treat diabetes in 
Asia and Australia (Raman et al., 2012). Despite their characteristically bitter taste, they 
are considered to have prophylactic properties and are oftenincluded in the diet (Bailey et 
al., 1986). In India and China, karela is crushed and dried to form tablets (Duke, 1985 
and Vad, 1960). Aerial parts of a wild variety of M. charantia (cerasee) are prepared as a 
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decoction in Central America for the same purpose (Bailey et al., 1985). Asian and West 
Indian immigrants have recently introduced karela and cerasee into Europe as adjuncts 
and alternatives to conventional treatments for NIDDM (Bailey et al., 1986). 
Consumption of 50 ml of an aqueous extract of karela with a 50-g oral glucose challenge 
reduced glucose concentrations of NIDDM patients by ~20% within 1 h (Leatherdale et 
al., 1981). A similar improvement in glycemic control was noted after 2-3 mo of daily 
consumption of karela (Leatherdale et al., 1981 and Akhtar, 1982). Hypoglycemic 
effects of raw karela and aqueous karela extracts have also been reported in healthy and 
alloxan-induced diabetic animals (Leatherdale et al., 1981; Akhtar, et al., 1981; 
Sharma et al., 1960). Oral consumption of karela does not enhance insulin release, 
although an aqueous extract of karela has been shown to stimulate insulin release from 
normal isolated islets in vitro (Leatherdale et al., 1981; Welihinda et al., 1982).  It has 
been claimed that karela contains insulin like peptide that lowers glucose concentrations 
when injected subcutaneously into insulin-dependent diabetes mellitus (IDDM) patients, 
but this is unlikely to account for the oral hypoglycemic effect of karela in NIDDM 
(Khanna et al., 1981). Another purportedly hypoglycemic fraction isolated from karela 
and called charantin is a mixture of glycosides, mainly p-sitosterol-D-glucoside and 
stigmadine glucoside (Sucrow, 1965). Fractionation of karela has indicated at least two 
orally active hypoglycemic principles: an uncharacterized rapidly effective substance, 
and a slowly acting material that is present in an alkaloid-rich fraction. Large quantities 
of karela extract induced testicular lesions in dogs, and hepatic portal inflammation has 
been anecdotally ascribed to excessive consumption of cerasee (Dixit et al., 1978). 
Various glycoside-containing fractions have been implicated as hypoglycemic 
constituents of traditional antidiabetic plants. Momordica diocia has also been shown to 
possess significant anti-diabetic activity at a dose of 250mg/kg orally (Jyothsna et al., 
2012). Momordica foetida, a remedy used mainly in West Africa, exerted a mild 
hypoglycemic effect in healthy rabbits (Olaniyi, 1975). M. foetida, like karela, contains 
the glycoside fraction charantin. 
In the sixth century BC, the Indian physician Sushruta prescribed a mixture of plants for 
diabetic patients, including Gymnema sylvestre (gurmar) (Shanmugasundaram et al., 
1983). Gurmar is still used as a treatment for NIDDM patients in Asia and has been 
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studiedin healthy and alloxan-induced diabetic rabbits (Shanmugasundaram et al., 
1981; Shanmugasundaram et al., 1983). Gurmar appeared to act in part by increasing 
insulin release and was ineffective in pancreatectomized animals (Shanmugasundaram, 
et al., 1981). The hypoglycemic effect was slowly generated and sustained and has been 
attributed to an uncharacterized glycoside. In alloxan-induced diabetic rabbits consuming 
250 mg/kg/day dried powdered leaves, glucose concentrations were halved after 24 wk, 
glycogenesis and protein anabolism were improved, and the activity of insulin-dependent 
enzymes such as hexokinase and glycogen synthase was increased 
(Shanmugasundaram, et al., 1983). Serum enzymes and histological observations 
suggested reduced tissue damage in diabetic animals treated with gurmar, but clinical 
accounts have noted that this plant can reduce or abolish the taste sensations of sweetness 
and bitterness. 
Leaves of Vaccinium myrtillus (bilberry) were widely used as a treatment for diabetes 
before the availability of insulin, and an active glycoside principle (neomyrtillin) was 
extracted (Allen, 1927). The active extract was reputedly effective in reducing glycosuria 
and postprandial hyperglycemia in most adult-onset diabetic patients but was seldom 
effective in juvenile-onset patients. The extract was found to enhance the hypoglycemic 
action of exogenous insulin and reduced insulin requirements, fostering the view that the 
extract might facilitate insulin action (Allen, 1927; Wilder and Allan, 1928). Vaccinium 
myrtillus extracts are anecdotally claimed to be well tolerated and did not produce any 
obvious adverse side effects during chronic administration. 
An aqueous extract of stem bark from Ficus benghalensis (banyan tree), used 
traditionally in Asia, contains a flavonoid glycoside termed bengalenoside .This produced 
a mild hypoglycemic effect in healthy and alloxan-induced diabetic rodents 
(Brahmachari and Augusti, 1964). Ficus extracts were not effective in 
pancreatectomized animals, and modest doses were toxic in some species. 
Cyamopsis tetragonolobus (Indian cluster bean) is recognized in Asian folklore as a 
useful aid for the diabetic subject (Pillai et al., 1980). Seeds of this plant are the source of 
galactomannan gum (guar that is used as a bulking agent for foods and cosmetics) (Day, 
1986). The viscosity effect of guar is exploited as a dietary adjunct to delay the rate of 
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glucose absorption and thereby helps to reduce postprandial hyperglycemia (Jenkins et 
al., 1976). In addition to the guar seeds, the pods of the Indian cluster bean are also 
believed to contain an antidiabetic principle (Pillai et al., 1980). Closely related and 
similarly effective to guar gum is the polysaccharide glucomannan, which was isolated 
from tubers of Amorphophallus konjac (konjac plant) (Doi et al., 1979). This is a 
traditional Japanese aid for diabetes. The efficacy, mode of action, and precautions 
associated with the use of guar and other dietary fiber supplements have recently been 
reviewed (Vinik and Jenkins, 1988). 
Several antidiabetic treatments from the Orient have recently been shown to contain 
antihyperglycemic polysaccharides and peptidoglycans (i.e., Aconitum carmichaeli, 
Anemarrhena asphodeloides, Atractylodes japonica, Dioscorea japonica, 
Eleutherococcus senticosus, Ephedra distachya, Ganoderma lucidum, Lithospermum 
erythrorhizon, Oryza sativa, Panax ginseng, Panax quinquefolium, and Saccharum 
officinarum) (Konno et al., 1985; Takahashi et al., 1985). At doses up to 100 mg/kg 
body wt, the principles from these plants lowered glucose concentrations in healthy and 
alloxan-induced diabetic mice within 7 h. The most common polysaccharide or 
peptidoglycan principle from each plant reduced glucose concentrations by >20% in the 
alloxanized mice, and the hypoglycemic effect was often still in evidence after 24 h. 
Because the principles were effective after intraperitoneal administration, it has been 
suggested that their mode of action is different than the intestinal fiber effect of guar and 
glucomannan. Although the plants are known to contain other extracts with different 
pharmacological effects (e.g., central nervous system stimulation and hypertensive effects 
of ephedrine from Ephedra species and central nervous system stimulation by Panax 
species), the toxicology of the polysaccharide and peptidoglycan principles has not been 
reported. 
Another group of hypoglycemic principles is the hypoglycins (aminopropylpropionic 
acid derivatives isolated from the unripe fruits of Blighia sapida [ackee fruit]), a 
traditional treatment for diabetes in Central America and Africa (Bressler et al., 1969). 
Hypoglycins are effective in healthy and diabetic animals and humans, promoting 
glucose use and inhibiting gluconeogenesis secondary to the inhibition of long-chain fatty 
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acid oxidation (Bressler et al., 1969). However, their toxic effects have precluded further 
development. The unripe fruits of B. sapida are well recognized to induce 
neuroglycopenia if consumed by fasting individuals, but awareness of the risk has not 
prevented excessive fatality (Bressler et al., 1969). Children are especially susceptible, 
presenting with listlessness, nausea, and convulsions, the so-called vomiting sickness of 
the West Indies.  
The traditional use of Galega officinalis (goat's rue or French lilac) in medieval Europe is 
explained by its rich content of the hypoglycemic substance guanidine (Hermann 1973; 
Petricic and Kalogjera, 1982). Although guanidine proved too toxic for clinical use, the 
alkyl diguanides synthalin A and synthalin B were introduced as oral antidiabetic agents 
in Europe in the 1920s but were discontinued when insulin became more widely 
available. Experience with guanidine and diguanides prompted the development of 
biguanides and the current use of metformin (Hermann, 1973; Mertz, 1982). 
Some antidiabetic plants used in underdeveloped regions may be helpful for nonclassical 
types of diabetes such as tropical pancreatic diabetes, type J, type K, and other forms of 
malnutrition diabetes (Mohan et al., 1985; Kanter et al., 1984). For example, Poterium 
spinosum is an ion-rich antidiabetic plant used by nomadic Bedouins in desert regions of 
the Middle East (Steinmetz et al., 1964). Consumption of a root infusion for 1 - 2 
months is reported to eliminate symptoms of diabetes for at least 1 yr (Rubenstein, 
1962). 
Traditional use of an infusion of Medicago sativa (alfalfa) leaves in South Africa may be 
associated with the high manganese content of this plant (Reddy and King, 1987). 
Manganese chloride has been shown to exert a hypoglycemic action in an IDDM patient, 
and manganese is now recognized as a necessary cofactor for ATP phosphorylation of the 
(3-subunit of the insulin receptor (Reddy and King, 1987; Swanston et al., 1961). An 
antidiabetic effect of alfalfa, which has been substantiated in streptozocin-induced 
diabetic mice, might also be associated with the plant's high concentration of vitamin K 
(Kuo, 1969). The synthetic analogue vitamin K5 can acutely mimic certain actions of 
insulin (Mertz, 1976). Widespread use of Saccharomyces cerivisae (yeast) as a 
traditional treatment for diabetes may be correcting deficiencies of vitamin B complexes 
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or chromium. Chromium deficiency has been implicated as a contributory cause of 
insulin resistance in certain types of diabetes, and chromium is believed to be the so 
called glucose tolerance factor in yeast (Mohan et al., 1985; Urumow and Wieland, 
1984; Caulfield, 1979; Wiedenkeller and Sharp, 1983). 
Coleus forskohlii does not appear to have been used as a traditional treatment for 
diabetes, but the diterpene forskolin from this plant stimulates glucose-induced insulin 
secretion in vitro (Whetton et al., 1983). This appears to reflect a general stimulatory 
influence of forskolin on adenylate cyclase activity, obviating its specific suitability as an 
antidiabetic treatment (Ahmad et al., 1984). A. bisporus consumption improved insulin 
sensitivity in diabetic mice, and a lectin from this mushroom stimulated insulin release by 
isolated islets of healthy rats (Ahmad et al., 1984). 
Eremurus persicus is used as an antidiabetic agent in Iranian traditional medicine, the 
antiglycation activity of this species was evaluated. The active compound isolated was 
identified as 5,6,7-trimethoxy-coumarin. 5,6,7-trimethoxy-coumarin exhibited a good  
antiglycation activity (Asgarpanah et al., 2011). 
A number of new plants have been studied for their possession of antidiabetic potential in 
recent years as diabetes is rising on a war footing.  Many such studies have came up with 
positive results and these need to be further extended to look for the new 
phytocompounds which may pave way for the development of new drugs in the treatment 
of diabetes. Some of these are Caesalpinia bonduc (Jana et al., 2010), Cassia glauca 
(Salahuddin et al., 2010), Cassia siamea (Kumar et al., 2010), Cinnamomum 
zeylanicum (Shen et al., 2010), Coccinia indica (Gunjan et al., 2010), Hybanthus 
enneaspermus (Patel et al., 2011), Afzelia africana (Oyedemi et al., 2011), Amaranthus 
(Girija, et al., 2011), Annona squamosa (Basha et al., 2011), Boerhaavia diffusa 
(Chauhan et al., 2011), Berberis vulgaris (Meliani et al., 2011), Brassica juncea 
(Thirumalai et al., 2011), Smilax china (Raju et al., 2012), Acorus calamus (Prisilla et 
al., 2012), Wrightia tinctoria (Shruthi et al., 2012), Aristolochia indica (Karan et al., 
2012), Artocarpus Heterophyllus (Shahin et al.,2012 ), Bauhinia purpurea (Pahwa et 
al.,2012), Carica papaya (Maniyar et al., 2012) and so on. 
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Even though antidiabetic activity of crude extracts and purified active constituents 
of many plants are identified, studies related to the restorative activity of medicinal plants 
with reference to the diabetes associated altered metabolic functions are very scanty. 
Despite the understanding that normalization of hyperglycemia could prevent the 
majority of diabetes complications, the available treatment regimens cannot adequately 
normalize blood glucose levels in diabetic patients. Thus, there is a need for agents that 
can achieve better glycaemic control. Over the years, various medicinal plants and their 
extracts have been reported to be effective in the treatment of hyperglycemia and diabetes 
(Marles and Farnsworth, 1995). The hypoglycemic actions of some of these 
phytochemical constituents have been evaluated and confirmed in animal models 
(Hwang et al., 2005 and Vinson and Zhang, 2005) suggesting that natural products 
could serve as a source in the search for effective antidiabetic agents.  
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Plant under study 
 
Figure 1: Eremurus himalaicus 
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Scientific Classification 
 Kingdom:  Plantae 
 Phylum:  Tracheophyta 
 Class:   Spermatopsida 
 Order:  Asperagales 
 Family:  Asphodelaceae 
 Genus:  Eremurus 
 Species:  himalaicus 
 Eremurus is a genus of 35-40 deciduous perennial flowers, also known as 
the foxtail lilies or desert candles. The inflorescence looks similar to a long spike or a 
bottlebrush. It consists of many flowers in copper, bright yellow, snow white, pastel pink, 
orange or any combination of these colors. The leaves grow in tufts of thin, green, strap 
like strips. Species are known for thick roots that grow out from a central hub. It is also 
known for being tall, sometimes rising up to 10 feet over the foliage, depending on the 
variety. These plants are native to western and central Asia. Some of the species of 
Eremurus are as Eremurus himalaicus, Eremurus elwesii, Eremurus bungei, Eremurus 
olgae, Eremurus tubergenii, Eremurus warei, Eremurus shelfordii, Eremurus 
stenophyllus, Eremurus robustus (Mark and Gerard, 2004). 
  Eremurus himalaicus (Himalayan Desert Candle) is a plant that can be easily 
identified by its tall stout spike-like cluster of hundreds of white flowers with protruding 
orange anthers (Nayer et al., 1987). When in bud, the flower-spikes look like candles, 
inspiring the common name. Flower clusters are 30-40 cm long, each flower being about 
an inch across, borne on a long stalk, in the axils of awn-shaped papery bracts. Petals are 
oblong blunt, with brown line on the outside. Leaves are all at the base, narrow, 1-3 ft 
long, 2-4 cm wide, erect. Eremurus himalaicus is wild ornamental and edible herb found 
on rocky slopes of the drier areas of Himalayas, from Afghanistan to Himachal Pradesh, 
at altitudes of 2100-3300 m asl. 
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 Locally known as Hulla, Kaihloon, Dharshaag, Chhil haak, Bulkutor Yalun, is 
exploited for its edible leaves and roots. Leaves are cooked as vegetable. In Kishtwar 
district, edible young leaves are sold in the market during March-April. In Lahul-Spiti 
and Ladakh the tribals obtain considerable part of their daily food from the wild plants 
and Eremurus himalaicus is one of them (MOEF, 1999; O.P. Sharma, 2008; Satish and 
Irshad, 2009). Sirmour district in Himachal Pradesh  is almost  entirely a hilly and  
mountainous district with an interacting  mosaic of mountain ranges, hills and the  use  of  
the  traditional  medicine  is  widely accepted by tribal in Sirmour valley. The reliance on 
folk medicine for healthcare is associated with the traditional belief of effectiveness.  
Young leaves of Eremurus Himalaicus (Asphodelaceae) locally named as 'Tache' are 
used as vegetables in case of anaemia (Shailja, 2011). The primitive people of all ages 
had knowledge of medicinal plants and this knowledge is still alive and several hundred 
species are used as herbal remedies in indigenous system of medicines. Eremurus 
himalaicus leaves are widely used as a galactagogue by practitioners of traditional 
systems of medicines (Dhiraj and Anjna, 2011). Hordenine (N, N-dimethyltyramine) is 
a phenylethylamine alkaloid isolated from the Eremurus himalaicus. The maximum 
presence of Hordenine is in the roots of this plant and it possesses many activities like 
antiasthmatic, uterine stimulant, insect repellent, antifeedant, radioprotector, similar 
action as ephedrine and concentration-response sex activity. It stimulates the release of 
norepinephrine in higher animals, and helps people lose weight. It also possesses 
antibacterial and antibiotic properties (Zhou et al., 2010; www.globalimporter.net; 
www.guidechem.com). Chelidonic Acid has been has also been isolated from the leaves 
of Eremurus himalaicus (Buch, 1980). An herbal formulation of Daldali unarnava and 
Bhains Dhenti with Eremurus himalaicus Baker has been used in the treatment of 
Migraine with Insomnia (www.flickr.com). Till date no scientific research work has been 
done on the medicinal values of this plant and a lot is needed to be explored. 
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The designing of methodology involves a series of steps taken in a systematic 
way in order to achieve the set goal(s) under the prescribed guidelines and 
recommendations. It includes in it all the steps from field trip to the observation including 
selection and collection of the medicinal plant, selection of dose value, standardization of 
protocol, usage of instruments, preparation of reagents, selection of specific solvents for 
extraction, formation of protocols and final execution of the standardized protocol. All 
this requires good build of mind and a good and soft technical hand to handle the 
materials and procedure in a true scientific manner. 
 
3.1 Chemicals 
 Chemicals used in this study were of analytical grade and of highest purity 
procured from standard commercial sources in India.  
Name of chemical                                       Source/Make 
Alkaline phosphatase  kit    Erba 
Alloxan monohydrate      Sigma Aldrich 
Cholestrol kit       Erba 
Diethyl ether       Rankem 
DMSO       Labo chemie 
Eosin       MERK 
Ethanol      Rankem 
Ethyl acetate      Rankem 
Formalin      MERK 
Glibenclamide      Sigma Aldrich 
Glucose kit       Erba 
Glucose/Sucrose                                            Qualigens 
Hematoxylin      MERK 
Isopropyl alcohol     Rankem 
Methanol       Rankem 
Petroleum ether     Rankem 
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Picric acid      MERK 
SGOT kit       Erba 
SGPT kit      Erba 
Sodium chloride     Qualigens 
Triglycerides kit      Erba 
Xylene       MERK 
 
3.2 Instruments 
 Following instruments were required for the study: 
Name of the instrument                                              Source 
Autoanalyser      Sysmex 
Automatic knife sharpener     Yorco 
Centrifuge       Remi 
Cylomixer       Spinix 
Desiccator      Borosil 
Digital weighing balance     ANAMED India 
Distillation unit      Qualigens 
Glucometer      Accucheck Go 
Grinding mill      Hamburg 
Heating mantle     MAC 
Micro centrifuge      Remi 
Microtome       York Scientific Industries 
Oven        Bells India 
Refrigerator      LG 
Rotary evaporator      Lab Sil 
Soxhlet extractor               Fisher 
Tissue floatation bath  Teknik 
Water bath               Techno India 
Wax dispenser     Yorco 
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 3.3 Experimental animals 
 Healthy adult Albino Wistar rats of 190-220 g of either sex were selected for the 
study. The animals were obtained from Regional Research Institute of Unani Medicine 
(RRIUM). The animals were housed in standard cages and kept under standard condition. 
They were given a standard diet and water ad libitum. Animal studies had approval of 
IAEC, RRIUM Srinagar constituted by Committee for the Purpose of Control and 
Supervision of Experiments on Animals (CPCSEA). 
 
3.4 Plant Material Collection  
        The plant Eremurus himalaicus was collected from the Faqir Goojree, Dhara, 
Srinagar Kashmir in the month of May and was identified and authenticated from The 
Centre for Biodiversity and Taxonomy, Department of Botany, University of Kashmir. 
The voucher specimen has been retained in the herbarium of The Centre for Biodiversity 
and Taxonomy, Department of Botany, University of Kashmir for future reference under 
herbarium number: 1765 (KASH). The plant material was cleaned, reduced to small 
fragments, air dried under shade at room temperature and coarsely powdered in a 
grinding mill. The powdered material was stored or taken up for extraction process. 
 
3.5 Preparation of plant extracts 
          The powdered plant material was successively extracted in 250ml each of 
petroleum ether, ethyl acetate, methanol and distilled water by using Soxhlet extractor.  
The plant material was suspended in the main chamber of Soxhlet extractor which was 
then placed onto a flask containing the extraction solvent. The Soxhlet was then equipped 
with a condenser. The flask was heated; the solvent evaporated and moved up into the 
condenser where it was converted into a liquid that trickled into the extraction chamber 
containing the sample. The chamber containing the solid material was slowly filled with 
warm solvent. When the Soxhlet chamber was almost full, the chamber was 
automatically emptied, with the solvent running back down to the distillation flask. This 
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cycle was repeated many times, over hours or a few days, until the colour of the solvent 
in the siphon of the soxhlet faded away. 
           At the end of the hot extraction process each extract was filtered. The filtrate was 
concentrated and the solvent was recovered using rotary evaporator. The extracts were 
then kept in desiccators to remove remaining moisture, if present, and finally stored in air 
tight containers at 4
o
C for further use.  
 
3.6 Preliminary phytochemical analysis of the extracts 
 The extracts so obtained were subjected to preliminary phytochemical screening. 
Phytochemical studies were performed to identify the presence of various 
phytoconstituents as follows: 
3.6.1 Tannins 
To 2 ml of aqueous extract 2 ml of 5% FeCl₃ was added and observed for the formation 
of yellow brown precipitate (Jigna and Sumitra, 2007). 
3.6.2 Alkaloids 
To the 2 ml methanolic filtrate, 1.5 ml of 1% HCl was added. After heating the solution 
in water bath, 6 drops of Mayor’s reagents/Wagner’s reagent/ Dragendroff reagent was 
added. Formation of Orange precipitate was observed to detect the presence of alkaloids 
(Oguyemi, 1979). 
3.6.3 Saponins 
Aqueous extract of 2 g powder was made and the solution was shaken vigorously and 
observed for a stable persistent froth. The frothing was mixed with few drops of olive oil 
and shaken vigorously after which it was observed for the formation of an emulsion 
(Sofowora, 1993). 
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3.6.4 Cardiac glycosides 
To 2 ml alcoholic filtrate, 1 ml glacial acetic acid and 1-2 drops of FeCl₃ was added 
followed by 1 ml of concentrated H₂SO₄. A brown ring at the interface indicated the 
presence of a deoxysugar characteristic of cardenolides. A violet ring may appear below 
the brown ring, while in the acetic acid layer a greenish ring may form just above the 
brown ring and gradually spread throughout this layer (Trease and Evans, 1989). 
3.6.5 Terpenes 
To 2 ml of aqueous extract, 5 ml chloroform, 2 ml acetic anhydride and concentrated 
H₂SO₄ were added carefully to form layer. Reddish brown coloration of interface was 
observed to detect the presence of terpenes (Harborne, 1973). 
3.6.6 Flavonoids 
2 g plant material was extracted in 10 ml alcohol or water. To 2 ml filtrate few drops of 
concentrated HCl followed by 0.5 g of zinc or magnesium turnings was added. The 
solution was observed for the appearance of magenta red or pink color after 3 minutes 
(Jigna and Sumitra, 2007). 
3.6.7 Phenolics 
To 2 ml of alcoholic or aqueous extract, 1 ml of 1% ferric chloride solution was added. 
Blue or green color indicated phenols (Martinez and Valencia, 2003). 
3.6.8. Anthraquinones 
0.5 g of the extract was boiled with 10 ml of sulphuric acid (H2SO4) and filtered while 
hot. The filtrate was shaken with 5 ml of chloroform. The chloroform layer was pipetted 
into another test tube and 1 ml of dilute ammonia was added. The resulting solution was 
observed for colour changes (Harborne, 1973). 
 
3.7 Physicochemical parameters 
 The standardization of the drug was carried out as per Unani Pharmacopeia. The 
various physicochemical parameters that were determined include: 
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3.7.1 Description 
The plant was evaluated by the organs of sense (skin, eye, tongue, nose and ear) or 
macroscopic evaluation and it included evaluation of plant by color, odor, taste, size, 
shape and special feature, like touch, texture etc. 
3.7.2 Loss on drying 
About 10 g of plant material was placed (without preliminary drying) after accurately 
weighing (accurately weighed to within 0.1g) it in a tarred evaporated dish. This was 
dried at 105
o
C for 5 hrs and weighed. Drying and weighing was continued at 1 hr interval 
until difference between two successive weighing corresponded to not more than 0.25%. 
Constant weigh was reached when two consecutive weights, after drying for 30 min. and 
cooling for 30 min. in a desiccator, showed not more than 0.1 g difference. 
3.7.3 Extractive values (Successive) 
A known amount of plant material was taken and all the sugars were leached out with 
cold water, dried thoroughly in a desiccator till weight was constant and then extracted 
successively with petroleum ether, ethyl acetate, methanol and water in a Soxhlet 
extractor for complete extraction and different extracts were weighed quantitatively and 
percentage with respect to the weight of the plant material taken was calculated. 
3.7.4 Total ash value: 
About 2-3g accurately weighed ground plant material was incinerated in a tared 
platinum/slica crucible at a temperature not exceeding 450°C until free from carbon. 
Then it was cooled and weighed. If a carbon free ash cannot be obtained in this way, the 
charred mass could be exhausted with hot water, the residue collected on an ash less filter 
paper, the residue and filter paper were incinerated, the filtrate was added, evaporated to 
dryness, and ignited at a temperature not exceeding 450°C. The percentage of ash with 
reference to the air dried plant material was calculated. 
3.7.5 Acid insoluble ash value 
To the crucible containing total ash, 25ml of diluted HCl was added. The insoluble matter 
was collected on an ash less filter paper (Whatmann no. 41) and washed with hot water 
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until the filtrate was neutral. The filter paper containing insoluble matter was transferred 
to the original crucible and dried on a hot plate and ignited to constant weight. The 
residue was allowed to cool in a suitable desiccator for 30 minutes and weighed without 
delay. The content of the insoluble ash was calculated with reference to the air dried plant 
material. 
3.7.6 Water soluble ash value  
The ash was boiled for 5 min with 25ml of water; insoluble matter was collected in a 
Gooch crucible or on an ash less filter paper, washed with hot water, and ignited for 15 
minutes at a temperature not exceeding 450°C. The weight of the insoluble matter was 
subtracted from the weight of the ash; the difference in weight represented the water 
soluble ash. The percentage of water soluble ash was calculated with reference to the air 
dried plant material. 
3.7.7 Residue on ignition/ Sulfated Ash test 
A platinum/silica crucible was heated to redness for 10 min, allowed to cool in a 
desiccator and weighed. 1-2 g of the plant material was put, accurately weighed, into the 
crucible; ignited gently at first, until the substance was thoroughly charred. The residue 
was cooled, moistened with 1 ml of H2SO4, heated gently until white fumes were no 
longer evolving and ignited at 800°C±25°C until all black particles disappeared. The 
ignition was conducted in a place protected from air currents. The crucible was allowed 
to cool; a few drops of H2SO4 were added and the crucible was heated. Then it was 
ignited as before, allowed to cool and weighed. The operation was repeated until two 
successive weighing didn't differ by more than 0.5mg. 
3.7.8 pH value at 10% and 1% dilution 
pH of 10%  solution: Dissolve an accurately weighed 10 g of drug in accurately measured 
100ml of water, filter and check the pH of filtrate with a standardized glass electrode. 
pH of 1% solution: Dissolve an accurately weighed 1 g of drug in accurately measured 
100ml of water, filter and check the pH of filtrate with a standardized glass electrode. 
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3.8 Acute toxicity testing 
 Studies were carried out in order to check the toxic effects of the extracts. The 
study was performed as per Organization for Economic Cooperation and Development 
(OECD) guidelines no 425. Rats were used for this purpose. The animals were fasted 
overnight, providing only water, after which the extract was administered to the 
respective groups orally at the dose level of 2000 mg/kg body weight by gastric 
intubation and the groups were observed continuously for 24 hrs for behavioral, 
neurological and autonomic profiles, and then at 24 hrs and 72 hrs for any lethality. The 
animals were further observed for toxic symptoms for 14 days. According to the 
guidelines if mortality is observed in 2 or 3 animals, then the dose administered is 
assigned as a toxic dose. If mortality is observed in one animal, then the same dose is 
repeated again to confirm the toxic dose. If mortality is not observed at all, the plant 
extract is considered as non-toxic. Alternatively, the toxicity test is started with a dose of 
100 mg/kg body weight and repeated for further other doses such as 250, 500, 1000 and 
finally 2000 mg/kg body weight. 
 
3.9 Effect of different extracts of Eremurus himalaicus on Diabetic rats  
3.9.1 Effect of different extracts on physiological and biochemical parameters 
1. Healthy Wistar strain albino rats were selected and randomly divided into five groups 
with six animals in each group serving as group ‘A’ = normal, group ‘B’= diabetic 
control, group ‘C’ = diabetic group given 250 mg/kg b. wt of the extract, group ‘D’ = 
diabetic group given 500 mg/kg b. wt of the extract, and group ‘E’ = reference control i.e. 
standard drug (glibenclamide, 30 mg/kg b. wt.). 
2. An identification mark was given to the rats of each group using picric acid as dye 
following standard procedure of DSRU-RRIUM, Sgr. [RRISGR/SOP-AH/002 (Animal 
identification marking)]. Each rat of a group was marked at a specific position viz.- Head; 
Back; Tail; Head and Back; Head and Tail; and one was left Blank i.e. unmarked. Each 
rat was weighed and the doses were calculated accordingly. 
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3. Diabetes was induced in each group using freshly prepared solution of Alloxan 
monohydrate dissolved in normal saline (0.91% w/v of NaCl) except the group "A” 
which served as normal control. For inducing diabetes the rats were kept on fasting for 18 
hours and diabetes was induced by giving a single IP injection of Alloxan monohydrate 
(100 mg/kg b. wt.) following standard methodology of DSRU-RRIUM, Sgr. 
[RRISGR/SOP-TX/008 (Intraperitoneal route of drug administration)]. To prevent fatal 
hypoglycemia due to massive pancreatic insulin release, the rats were provided with 20% 
glucose solution after six hours supplied in water bottles in their cages for next 24 hours. 
4. The fasting blood glucose level of the rats was measured after 72 hours. The rats 
having fasting blood glucose level above 200mg/dl were selected for further 
experimentation. 
5. Group ‘A’ was fed with simple drinking water which served as normal control; group 
‘B’ in which diabetes was induced was also fed with simple drinking water, serving as 
Diabetic control; Group ‘C’ in which diabetes was induced was given 250 mg/kg b. wt. 
of extract orally; Group ‘D’ in which diabetes was induced was given 500 mg/kg b. wt. of 
extract orally and;  group ‘E’ in which diabetes was induced was given the standard drug 
glibenclamide (30 mg/kg of b. wt) orally by the help of 18 No. cannula following 
standard methodology of DSRU-RRIUM, Sgr. [RRISGR/SOP/TX/001 (Dosing of rats by 
oral route)]. All the groups were given respective treatments daily for 14 days. 
6. Blood was collected on the 0
th
 day, means the day on which the dosing was started, 7
th
 
day and 14
th
 day, through the retro orbital sinus of the rats. 
7. Physiological parameters like food intake, fluid intake, urine excretion and body 
weight were monitored during the experimentation as per standard methodology of 
DSRU-RRIUM, Sgr. [RRISGR/SOP-TX/010 (Recording of water consumption)], 
RRISGR/SOP-TX/009 (Recording of food consumption) and [RRISGR/SOP-TX/012 
(Urine analysis)]. In order to check the effect of the extracts on the weight of rats, weight 
of the rats was recorded prior to the administration of the extracts and at the end of the 
study i.e. on the 14
th
 day. The urine volume may not be measured instead an overview 
was made by the wetting of saw (cage bedding) by urine. The initial and final amount of 
feed provided to rats in the cages was weighed and the average food intake value was 
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calculated. Similarly the average fluid intake was determined by measuring the initial and 
final volume of water. 
8. Estimation of Glucose and other clinical parameters: The serum from the blood was 
separated as under: 
 Sample was collected (preferably in glass tubes) and left for 1 hr at 37°C to allow it to 
clot. 
 Using a glass pasteur carefully the clot was loosened from the sides of the tube. 
 The serum was centrifuged at 3000 rpm for 10 min at 4°C. 
 The serum was removed from the clot by gently pipetting off into a clean tube using a 
glass pasteur or a micropipette. 
 The serum was labeled with the animal number and the estimations were made. The 
serum glucose level; the enzymes SGOT, SGPT and ALP level and the lipid profile (total 
cholesterol and triglyceride level) was determined enzymatically on Sysmex 
autoanalyser. 
 
3.9.2 Screening of dose dependence 
In order to check the dose dependence different doses of the extract(s) like 100, 300, 500, 
700, 1000 mg/ kg b. wt. were given to the different groups of rats following the same 
methodology as above. 
 
3.10 Effect of different extracts of Eremurus himalaicus on normal rats 
3.10.1 Oral Glucose tolerance test 
The oral glucose tolerance test was performed in overnight fasted (18hr) normal 
rats as per Bonner, 1988. Healthy rats were randomly selected and distributed into five 
groups (n=6). One of those groups was administered distilled water and the rest four 
groups were given orally ethyl acetate, methanol and aqueous extracts of Eremurus 
himalaicus (500 mg/kg bw., respectively) and glibenclamide (30mg/kg bw.). Glucose 
(2g/kg bw.) was fed 1 hr after the administration of extracts and glibenclamide. Blood 
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was withdrawn from the tail vein at 0, 60, 90,120 and 150 min of glucose administration 
and glucose levels were estimated using Accucheck Go blood glucose monitoring kit. 
 
3.10.2 Effect of different extracts on normoglycemic rats 
1. Healthy Wistar strain albino rats were selected and randomly divided into different 
groups with six animals in each group serving as group ‘A’ = normal control, group ‘B’= 
Ethyl acetate, 250 mg/kg b. wt.; group ‘C’ = Ethyl acetate 500 mg/kg b. wt.; group ‘D’ = 
Methanol, 250 mg/kg b. wt; group ‘E’ = Methanol, 500mg/kg b. wt.; 'F' = Aqueous, 250 
mg/kg b. wt. and 'G' = Aqueous, 500 mg/kg b. wt. 
2. An identification mark was given to the rats of each group using picric acid. 
3. The blood glucose level of the rats was measured after overnight fasting. 
4. Group ‘A’ was fed with simple drinking water which served as normal control and rest 
of the groups were fed with the respective extracts, mentioned above, orally following 
standard methodology. All the groups were given respective treatments daily for 14 days. 
5. Blood was collected again on the 7
th
 day and 14
th
 day of dosing, through the retro 
orbital sinus of the rats. 
6. The serum from the blood was separated and labeled with the animal number. The 
estimation of glucose level was measured enzymatically on an autoanalyser. 
 
3.11 Histopathological studies 
At the end of the study i.e. on 14th day the rats were sacrificed and the tissues 
(pancreas) were collected. The whole histopathological process was carried out in 
accordance with the SOPs (Standard Operating Procedures) of the lab of DSRU, RRIUM, 
Srinagar [RRISGR//SOP-TX/Histo/006 (Tissue fixation, Processing and Embedding)]. 
The rats were anesthetized by using diethyl ether. Using large scissors a cut was made 
laterally from just below the rib cage and extended fully to sides. Again using scissors 
another cut was made to cut the diaphragm fully on the border of the rib (from centre to 
sides).Using hemostats fasten to hold, the chest cavity was opened. Then pancreas was 
Chapter 3 
 
 Page 44 
 
removed in a systematic fashion and a requisite tissue sample was taken for the histology. 
The tissue sample was kept in 10% formalin for overnight. Then the sample was 
dehydrated in graded alcohol. Isopropyl alcohol was used. Dehydration was done by 
passing the tissue through increasing concentration of alcohol. 70% alcohol for 1 hour, 
90% alcohol for 1 hour, and 100% alcohol for 1 hour in an automatic tissue processor. 
After that it was cleaned in xylene. Dehydrated tissues were kept in a jar of alcohol-
xylene mixture for 30 min and then subjected to 2 changes of xylene of 30 min each. The 
pancreatic samples were then impregnated in paraffin wax (58-60 
0
C). After clearing, the 
tissue pieces were subjected to 2 changes of melted paraffin wax of 2 hours each. Then 
paraffin blocks were made in which samples were embedded and allowed to cool. 
Hardened blocks were taken for sectioning and staining as per the standard procedure of 
DSRU-RRIUM, Sgr. [RRISGR/SOP-TX/Histo/007 (Section cutting and Staining)]. All 
the tissue blocks were kept in freezer for 20-30 min before cutting. This process hardened 
the tissue blocks. Using automated microtome pancreatic samples were cut into sections 
of 5μ thickness and with the help of forceps placed in the tissue flotation bath which was 
kept at 40
0
C. Then the sections were lifted on slide and kept in a slide tray. This slide tray 
was kept in oven at 60
0
C for 5 min. The slide tray was then removed outside and let to 
cool. This process fixed the tissue section to the slide. Then again the slide tray was kept 
in oven for next 5 min. The hot slide was removed from the oven and placed in slide rack. 
The slide rack was dipped in a beaker containing xylene; the same was repeated in 
another beaker containing xylene. The slides were then subjected to staining using 
hematoxylin and eosin. The slide rack was passed through the decreasing concentration 
of alcohol. 100% alcohol 1 dip, 90% alcohol 1 dip, 80% alcohol 1 dip, 70% alcohol 1 dip 
and then dipped in a beaker containing tap water. After that the slide rack was immersed 
in hematoxylin jar for 15-20 min and then again dipped the slide rack in a beaker 
containing tap water. The slides were decolorized by a single dip in 1% acid alcohol and 
then dipped the in a beaker containing tap water. The slide rack was dipped in Scotts tap 
water (3-5 dips) for bluing and the slide rack was then dipped in a beaker containing tap 
water. The slides were counter stained by a dip in Eosin for 1 minute and again the slides 
were dipped in a beaker containing tap water. Then the slides were subjected to a single 
dip in 100% alcohol, 90% alcohol, 80% alcohol, 70% alcohol and in xylene. The extra 
Chapter 3 
 
 Page 45 
 
stain was cleaned with gauge dipped in xylene. The stained sections were mounted using 
DPX and covered with the cover slip. The slides were labeled with self sticking labels. 
The slides were then observed under microscope and photographed in order to check the 
effect of the extracts on the pancreas and the slides were then kept safely. 
 
3.12 Statistical analysis 
All the values of body weight, fasting blood sugar, and biochemical estimations 
were expressed as mean±standard deviation (S.D.) and analyzed for ANOVA and post 
hoc Dunnett's t-test. Differences between groups were considered significant at P<0.001 
and P < 0.05 levels. 
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4.1 Preliminary phytochemical analysis of the extracts 
 Phytochemical investigation of different extracts of Eremurus himalaicus 
revealed the presence of alkaloids, tannins, saponins, terpenoids, flavonoids, phenolics 
and cardiac glycosides as secondary metabolites. However, the extracts showed negative 
results for anthraquinones. 
 
4.2 Physicochemical parameters 
 The plant was tall erect, with medium green spike like foliage and white 
inflorescence. The successive extract value of pet ether, Ethyl Acetate, methanol and 
water extracts were found to be 2.30%, 3.10%, 26.12% and 14.6%. Total Ash value of 
plant material indicated the amount of minerals and earthy material attached to the plant 
material and its value was calculated to be 9.702 %w/w. The amount of the acid insoluble 
siliceous matter present in the plant was 8.826 %w/w. The water soluble extractive value 
was indicating the presence of sugar, acids and inorganic compounds and alcohol soluble 
extractive values indicated the presence of polar constituents and its value was found to 
be 1.427 %w/w. the value for residue on ignition was 0.963%w/w. the pH values of 1% 
and 10% solutions were 6.18 and 6.02 respectively. The value for loss on drying was 
found to be 1.419%w/w.; less value of moisture content could prevent bacterial, fungal 
and yeast growth.  
 
4.3 Acute toxicity testing 
 Acute toxicity studies revealed that the ethyl acetate, methanol and aqueous 
extracts of Eremurus himalaicus were safe up to 2000 mg/kg of body weight and 
approximate LD 50 is more than 2000 mg/kg. No lethality or any toxic reactions or 
moribund state was observed up to the end of the study period. This is not surprising as 
Eremurus himalaicus is used as a vegetable locally. 
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Table 2: Phytochemical analysis of extracts of Eremurus himalaicus 
Constituents Results 
Alkaloids + 
Tannins + 
Glycosides + 
Saponins + 
Anthraquinones _ 
Terpenoids + 
Flavonoids + 
Phenolics + 
+ Sign indicates Secondary metabolite is present; - Sign indicates secondary metabolite is not present. 
 
Table 3: General physicochemical parameters of Eremurus himalaicus 
S. No Test Parameters Results 
1. Description  
Medium green foliage, white 
inflorescence, Slightly bitter in taste 
2. Loss on Drying at 105°C 1.419%w/w 
3. 
Successive extract value 
 Pet. ether 
 Ethyl acetate 
 Methanol 
 Water 
 
2.30% 
3.10% 
26.12 % 
14.60% 
3. Total Ash 9.702 %w/w 
4. Acid Insoluble Ash 8.826 %w/w 
5. Water Soluble Ash 1.427 %w/w 
6. Residue on ignition/ Sulphated Ash 0.963%w/w 
7. pH of 1.00% w/v solution 6.18 
8. pH of 10.00% w/v solution 6.02 
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4.4 Effect of different extracts of Eremurus himalaicus on alloxan 
monohydrate induced diabetic rats 
4.4.1 Effect of different extracts of Eremurus himalaicus on physiological 
parameters 
The effect of different extracts on physiological parameters altered in diabetes 
like fluid intake, food intake, urine excretion and body weight is shown in Table 4 and 
Table 5 respectively. 
There is significant (p<0.001) increase in the fluid intake and food intake of the 
diabetic control group in comparison to the normal control group. However in the extract 
treated groups there is significant reduction in the fluid intake (p<0.001 for ethyl acetate 
and aqueous extracts; p<0.05 for methanol extract) and food intake (p<0.001 for ethyl 
acetate and aqueous extracts). Also the standard treated group shows significant decrease 
in the fluid and food intake of the rats (p<0.001). The methanol extract showed non-
significant decrease in the food intake (p>0.05). Also there is reduction in urine excretion 
in the extract and standard treated groups in comparison to the diabetic group. 
The table for the body weight changes shows that there is significant increase in 
the body weight of the extract and standard treated groups when compared to the diabetic 
group (p<0.001) over the period of 14 days. The diabetic group showed decrease in the 
body weight but the extract treated groups and the standard treated group showed 
increase in the body weight and the increase in body weight was more for standard 
treated group followed by ethyl acetate, aqueous and methanol extract treated groups. 
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Table 4:  Effect of the extracts of Eremurus himalaicus on food intake, fluid intake 
and urine excreted by alloxan monohydrate treated diabetic rats. 
Physiological 
Parameter 
 
Normal  
(water) 
 
Diabetic 
(water) 
 
Ethyl 
Acetate 
Extract 
500mg/kg 
Methanol 
Extract 
500mg/kg 
Aqueous  
Extract 
500mg/kg 
Glibenclamide 
10mg/kg 
Fluid 
intake 
(ml/day) 
38.43±4.87 63.66±6.06* 49.15±2.99* 56.35±4.99** 51.65±3.91* 46.55±4.18* 
Food 
intake 
(g/day) 
27.70±4.17 39.52±3.96* 25.88±3.96* 37.37±1.94 31.26±2.26* 25.35±3.23* 
Urine 
(wetting of  
saw-
bedding) 
 
+ 
 
++++ 
 
++ 
 
++ 
 
++ 
 
++ 
Data represented as mean ± S.D values of 6 animals each.  *p<0.001, **p<0.05 (Dunnett t-test); diabetic 
control was compared with the normal, extract and standard treated groups were compared with the 
diabetic control. 
 
Table 5: Effect of extracts of Eremurus himalaicus on body weight of Alloxan 
monohydrate induced diabetic rats. 
Groups 
Body weight (g) 
0th day 7th day 14th day % Variation 
Normal 207±4.99 209±4.35 212±3.77 2.41 
Diabetic control 202±5.75 196±4.32* 191±4.48* -5.44 
Ethyl Acetate Extract,  
500mg/kg 
210±5.49 216±6.30* 219±5.44* 4.29 
Aqueous  Extract, 
500mg/kg 
200±6.85 203±4.41 207±6.26* 3.5 
Methanol Extract,  
500mg/kg 
200±6.00 202±6.41 203±5.707* 1.5 
Glibenclamide,  
10mg/kg 
205±5.98 209±5.48** 214±4.62* 4.39 
Data represented as mean ± S.D values of 6 animals each.  *p<0.001, **p<0.05 (Dunnett t-test); diabetic 
control was compared with the normal, extract and standard treated groups were compared with the 
diabetic control. 
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4.4.2 Effect of different extracts of Eremurus himalaicus on metabolic parameters 
4.4.2.1 Effect of different extracts of Eremurus himalaicus on fasting blood glucose 
levels 
As shown in Table 6, the induction of diabetes has caused significant initial 
increase in the fasting blood glucose levels of all the groups. The diabetic control group 
shows significant increase throughout the study period when compared with the normal 
control group (p<0.001). However, the extract treated groups and the standard treated 
group shows significant decrease in the fasting blood glucose levels when compared with 
diabetic control (p<0.001) which was determined on the 7
th
 and 14
th
 day of experiment. 
The effect is more pronounced in standard (10mg/kg) group, followed by ethyl acetate 
(500mg/kg) group, aqueous (500mg/kg) group, ethyl acetate (250mg/kg) group, aqueous 
(250mg/kg) group, methanol (500mg/kg) group and methanol (250mg/kg) group with the 
percentage variations as shown in Table 6.  On the basis of these observations only ethyl 
acetate and aqueous extracts were selected for further analysis of antidiabetic activity. 
 
4.4.2.2 Effect of different extracts of Eremurus himalaicus on SGOT, SGPT and 
ALP levels 
 In case of the effect of ethyl acetate and aqueous extracts on liver enzymes 
(SGOT, SGPT and ALP), as shown in Figure 2, both the extracts show significantly 
lower levels of SGOT, SGPT and ALP in comparison to the diabetic control group 
(p<0.001). Here the maximum reduction was observed for standard followed by ethyl 
acetate extract. 
 
4.4.2.3 Effect of different extracts of Eremurus Himalaicus on serum lipid profile 
 Figure 3 shows the serum level of triglycerides and cholesterol and it can be seen 
that the diabetic group shows significant hyperlipidemia when compared with the normal 
control group. The extract treated groups and the standard treated group significantly 
decreased the serum levels of cholesterol and triglycerides when compared with the 
diabetic control group (p<0.001). The effect of ethyl acetate extract on serum lipid levels 
was even better than that of the standard treated group, showing the hypolipidemic 
potential of the plant. 
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Table 6: Effect of different extracts on fasting blood glucose levels of alloxan 
monohydrate induced diabetic rats. 
Groups 
Blood glucose level (mg/dl) 
0
th
  day 7
th
 day 14
th
 day % Variation 
Control 84.01±4.64 82.21±5.58 80.29±6.53 4.43 
Diabetic control 334.77±13.51* 356.20±16.53* 374.00±12.48* -11.72 
Ethyl Acetate Extract, 
250mg/kg 
342.30±13.46 274.60±14.51* 236.60±13.43* 30.78 
Ethyl Acetate Extract, 
500mg/kg 
328.80±11.14 257.30±15.15* 168.40±11.00* 48.78 
Aqueous  Extract, 
250mg/kg 
345.60±11.85 296.10±9.91* 257.70±11.56* 25.43 
Aqueous  Extract, 
500mg/kg 
342.80±10.90 270.80±9.67* 209.90±8.99* 38.77 
Methanol Extract, 
250mg/kg 
349.80±12.48 328.90±14.59** 309.50±9.07* 11.52 
Methanol Extract, 
500mg/kg 
330.10±10.2 288.00±9.54* 262.30±11.97* 20.54 
Glibenclamide, 
10mg/kg 
319.90±14.22 258.9±16.06* 154.40±16.88* 51.73 
Data represented as mean ± S.D values of 6 animals each.  *p<0.001, **p<0.05 (Dunnett t-test); diabetic 
control was compared with the normal, extract and standard treated groups were compared with the 
diabetic control. 
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Data represented as mean ± S.D values of 6 animals each.  *p<0.001 (Dunnett t-test); diabetic control was 
compared with the normal, extract and standard treated groups were compared with the diabetic control. 
Figure 2: Effect of different extracts of Eremurus Himalaicus on SGOT, SGPT and 
ALP levels of alloxan monohydrate induced diabetic rats. 
 
 
 
Data represented as mean ± S.D values of 6 animals each.  *p<0.001 (Dunnett t-test); diabetic control was 
compared with the normal, extract and standard treated groups were compared with the diabetic control. 
Figure 3: Effect of extracts of Eremurus Himalaicus on serum lipid profile of alloxan 
monohydrate induced diabetic rats 
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4.4.2.4 Histopathological studies 
In Figure 4, slide A and B represents islets of langerhans from normal and 
alloxan-induced diabetic rats, respectively. Comparison of these two slides clearly 
indicates the reduction in the number of β-cells in the islet of langerhans of pancreas of 
diabetic rats. As it is evident from slide B the islet is irregularly shaped, relatively small 
and atrophic. Most cells of the islets are small, degranulated and dark with scanty 
cytoplasm. However, compared to the untreated diabetic rats, histophatological 
examination of the plant Eremurus himalaicus extract-treated diabetic rats revealed an 
increase in the number of β-cells within the pancreatic islets, along with a reduction in the 
vacuolation (slides C, D and E). In other words, the plant extract treated diabetic samples 
histopathologically tend to approach the histopathology of the healthy pancreatic 
samples. The aqueous extract however shows less β-cell regenerative efficacy in 
comparison to ethyl acetate extract, showing that this extract might be producing 
hypoglycaemic effect in some other way. The standard treated group also shows recovery 
and tends to approach the histopathology of the normal rat pancreas. 
 
4.4.3 Screening of the Dose dependence 
 Different doses of the ethyl acetate and aqueous extracts were given to the 
different groups in order to determine the dose dependence of the extracts and the results 
are shown in Table 7.  It shows that the reduction in fasting blood glucose level by the 
ethyl acetate and the aqueous extracts is significant (p<0.001) at all the concentrations 
that were taken i.e., from 200mg/kg body weight up to 1000mg/kg body weight, however 
the percentage variation that represents the percentage increase/decrease in the blood 
glucose levels from Day0 to Day14 shows a systematic increase in the activity of the 
extracts in a dose dependent manner. 
 
 
 
 
Chapter 4 
 
 Page 54 
 
 
     
     
 
 
Figure 4: Micrographs of rat pancreas stained by haematoxylin and eosin of, 
(A) Untreated i.e. Normal control; (B) Alloxan induced diabetic rats i.e. Diabetic control; (C) 
Ethyl acetate extract of Eremurus himalaicus 500mg/kg body weight; (D) Aqueous  extract of 
Eremurus himalaicus 500 mg/kg of body weight); and (E) Glibenclamide 10 mg/kg of body 
weight). 
A B 
C 
E 
D 
Chapter 4 
 
 Page 55 
 
Table 7: Effect of different concentrations of Ethyl Acetate and Aqueous extracts of 
Eremurus Himalaicus on fasting blood glucose levels of alloxan monohydrate 
induced diabetic rats 
Groups 
Blood glucose level (mg/dl) 
0
th
  day 14
th
 day % Variation 
Control 85.31±7.0 86.82±9.38 1.77 
Diabetic control 344.47±9.01* 398.20±9.7* -15.60 
Ethyl Acetate Extract,  
200mg/kg 
349.15±14.29 245.94±15.41* 29.56 
Ethyl Acetate Extract,  
300mg/kg 
356.50±12.72 230.74 ±11.70* 35.27 
Ethyl Acetate Extract,  
500mg/kg 
330.69±10.51 178.85±14.19* 49.85 
Ethyl acetate Extract,  
700mg/kg 
322.52±12.86 143.80±13.00* 55.41 
Ethyl Acetate Extract,  
1000mg/kg 
350.35±12.75 135.48±13.96* 61.33 
Aqueous  Extract,  
200mg/kg 
335.73±15.67 259.70±11.70* 22.64 
Aqueous  Extract,  
300mg/kg 
341.56±10.90 246.91±10.95* 27.71 
Aqueous  Extract,  
500mg/kg 
350.61±14.89 219.58±14.78* 37.37 
Aqueous  Extract,  
700mg/kg 
329.22±12.97 175.61±13.10* 46.65 
Aqueous  Extract,  
1000mg/kg 
361.40±10.47 162.5±11.28* 55.03 
Data represented as mean ± S.D values of 6 animals each. . *p<0.001 (Dunnett t-test), diabetic control was 
compared with the normal and extract and standard treated groups were compared with the diabetic control. 
 
 
Chapter 4 
 
 Page 56 
 
4.5 Effect of different extracts of Eremurus himalaicus on normal rats 
4.5.1 Oral Glucose tolerance test 
 Oral administration of the extracts of Eremurus himalaicus at 500 mg/kg b. wt. 
prior to glucose load resulted in a significant fall in blood glucose level within 150 
minutes of administration of glucose load (Figure 5). 60 min prior administration of the 
extracts (500mg/kg of b. wt) followed by the glucose load didn’t allow the blood glucose 
level to go higher as compared to the normal ones. The effect was comparable to that of 
the standard antidiabetic drug, glibenclamide. Maximum effect was observed for aqueous 
and methanol extracts.  
 
4.5.2 Effect of different extracts of Eremurus himalaicus on fasting blood glucose 
levels of normoglycemic rats 
 The evaluation of the effect of extracts on blood glucose levels of 
normoglycaemic rats revealed the results that are in accordance with that of the results 
obtained for OGTT i.e., the aqueous extract (250mg/kg and 500mg/kg; p<0.001) 
followed by methanol extract (500mg/kg; p<0.05) shows significant decrease in the 
fasting blood glucose levels of the rats, however the ethyl acetate extract (250mg/kg and 
500mg/kg) and the methanol extract (250mg/kg) does not show significant lowering in 
the blood glucose levels of the rats (Table 8). The maximum reduction is shown by 
standard followed by aqueous extracts, thus showing the hypoglycaemic nature of the 
aqueous extract of Eremurus himalaicus plant. 
 
 
 
 
 
 
 
 
Chapter 4 
 
 Page 57 
 
 
 
 
Data represented as mean ± S.D values of 6 animals each.  *p<0.001, **p<0.05 (Dunnett t-test); diabetic 
control was compared with the normal, extract and standard treated groups were compared with the 
diabetic control. 
 
Figure 5: Effect of different extracts of Eremurus himalaicus and glibenclamide on 
Oral Glucose Tolerance of rats. 
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Table 8: Effect of different extracts of Eremurus himalaicus on fasting blood glucose 
levels of normoglycaemic rats 
Groups 
Blood glucose level (mg/dl) 
0
th
  day 7
th
 day 14
th
 day % Variation 
Normal Control 84.01±4.64 82.21±5.58 80.29±6.53 4.43 
Ethyl Acetate Extract,  
500mg/kg 
85.00±4.23 82.10±4.60 79.73±4.99 6.20 
Ethyl Acetate Extract,  
250mg/kg 
85.14±4.05 84.10±5.14 81.57±6.69 4.22 
Aqueous  Extract,  
500mg/kg 
81.64±3.72 72.5±3.44 65.58±2.86* 19.67 
Aqueous  Extract,  
250mg/kg 
81.40±4.08 73.36±2.67 68.51±2.92* 15.83 
Methanol Extract,  
500mg/kg 
81.53±2.38 77.26±1.65 72.74±2.15** 10.78 
Methanol Extract,  
250mg/kg 
84.35±6.21 79.30±4.03 76.08±2.37 9.80 
Glibenclamide,  
10mg/kg 
84.22±2.26 71.59±2.41* 65.36±3.80* 22.39 
 
Data represented as mean ± S.D values of 6 animals each.  *p<0.001, **p<0.05 (Dunnett t-test); diabetic 
control was compared with the normal, extract and standard treated groups were compared with the 
diabetic control. 
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Despite the fact that diabetes has high prevalence, morbidity and mortality 
globally, it is regarded as non curable but controllable disease. Different synthetic drugs, 
plant remedies and dietary modification play an effective role in the reduction of the 
suffering that it causes. The potential role of medicinal plants as antidiabetic agents has 
been reviewed by several authors (Grover et al., 2002; Schoenfelder et al., 2006; 
Kameswara Rao and Appa Rao, 2001; Tanko et al., 2007). In order to identify the 
plants with antidiabetic properties various plants have been tested in-vivo using animal 
models, for example rats, against the complications caused by inducers of diabetes, and it 
has been established that many plants possesses the potential to lower the fasting blood 
glucose levels and besides help in improving other diabetic complications. The sustained 
reduction in hyperglycemia automatically decreases the risk of other major complications 
of diabetes (Latha et al., 2004). Effective glucose control is the key for preventing or 
reversing the diabetic complications and improving the quality of life of the diabetics 
(Lefebvre, 2005). 
Many natural active compounds have been isolated from plants of different 
species. These active principles are complex carbohydrates, alkaloids, flavonoids, 
saponins, amino acids, steroids, peptides, terpenoids and others. These compounds have 
been shown to produce potent hypoglycemic, anti-hyperglycemic and glucose 
suppressive activities (Saxena et al., 2004). These effects might be achieved by 
facilitating insulin release from pancreatic ß-cells, inhibiting glucose absorption in gut, 
stimulating glycogenesis in liver and/ or increasing glucose utilization by the body 
(Grover et al., 2002; Saxena et al., 2004, Sezik et al., 2005, Marles and Fransworth, 
1995). These compounds may also exhibit antioxidant, hypolipidemic and anticataract 
activities, and restore enzymatic functions, repair and regeneration of pancreatic islets 
and the alleviation of liver and renal damage (Mukherjee et al., 2006). 
Crude ethyl acetate, methanol and aqueous extracts of Eremurus himalaicus at a 
dose of 500mg/kg showed significant effect on the glucose tolerance of rats and the 
aqueous and methanol extracts also showed reduction in the fasting blood glucose levels 
of the normoglycaemic rats, thus revealing the hypoglycaemic nature of the extracts.  The 
effect was more pronounced for aqueous extract. These findings indicate that the extracts 
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might be producing hypoglycaemic effect by a mechanism independent from the insulin 
secretion e.g. by the inhibition of endogenous glucose production (Eddouks et al., 2003) 
or by the inhibition of intestinal glucose absorption (Platel et al., 1997). 
Alloxan monohydrate is one of the chemical agents used to induce diabetes 
mellitus in animals. It induces diabetes by dose dependent destruction of β -cells of islets 
of langerhans.  It is a generator of free radicals of oxygen which cause extensive DNA 
damage (Szkudelski, 2001; Murthy et al., 2004). It was observed that single intravenous 
dose of alloxan exhibited significant hyperglycemia. Excessive hepatic glycogenolysis 
and gluconeogenesis associated with decreased utilization of glucose by tissues is the 
fundamental mechanism underlying hyperglycemia in the diabetic state. As the 
hyperglycemia induced by alloxan falls under category of mild diabetes and may reverse 
after a few weeks, the hypoglycemic effect of the plant in hyperglycemic rats was studied 
during 14 days treatment. The difference observed between the initial and final fasting 
serum glucose levels of extract treated hyperglycemic rats revealed antihyperglycemic 
effect of Eremurus himalaicus throughout the period of study. The effect of the extracts 
was compared to that of reference standard, glibenclamide and was found to be 
significant.   
The histopathological studies of the rat pancreas showed recovery of the alloxan 
induced damage of the insulin secreting beta pancreatic cells, thus providing a hint for the 
mechanism of action of the plant. In several parts of our body, tissue parts which have 
been damaged can be regenerated. However, it appears that in the absence of major 
external stimuli, the beta-cell population has only a very limited potential for 
regeneration. This is probably due to the limited replication capacity of beta cells and to 
the fact that neogenesis from precursor cells is not readily reactivated. Yet, under certain 
conditions where major external stimuli are applied, there can be a quite vigorous 
regenerative expansion of the beta-cell mass. Such regenerative growth may result from 
activation of otherwise quiescent precursor/progenitor stem cells (Bouwens and 
Rooman, 2005). 
An increase in the SGPT, SGOT and ALP activities was recorded in diabetic rats 
in comparison with non diabetic rats, indicating an altered liver function in diabetic 
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condition. Eremurus himalaicus extracts significantly controlled SGOT, SGPT and ALP 
values in the alloxan induced diabetic rats. In diabetic animals a change in the serum 
enzymes is directly related to changes in the metabolism in which these enzymes are 
involved. The increased levels of transaminases which are active in the absence of insulin 
because of increased availability of aminoacids in diabetes (Bondy et al., 1949; Felig et 
al., 1970) are responsible for the increased gluconeogenesis and ketogenesis observed in 
diabetes. In the present study, the Eremurus himalaicus extracts significantly decreased 
SGOT and SGPT enzyme activities. Hence, the improvements noticed in the levels of 
these enzymes are as a consequence of an improvement in the carbohydrate, fat and 
protein metabolism. The restoration of SGOT and SGPT levels after treatment also 
indicates a revival of insulin secretion. Elevation of ALP has been reported in diabetic 
rats (Mishima, 1967) and rabbits (Begum et al., 1978). This increase in ALP was 
significantly reversed by the extracts of Eremurus himalaicus. 
Moreover, hyperglycemia in diabetic rats was associated with a high serum 
concentration of total cholesterol and triglycerides as present in the normal diabetic 
conditions (Georg and Ludvik, 2000). However, ethyl acetate and aqueous extracts of 
Eremurus himalaicus at a dose level of 500 mg/kg and 250mg/kg reversed the diabetes-
induced hyperlipidemia compared to the diabetic control group. In extract treated rats, 
there was a reduction in the levels of cholesterol and triglycerides, showing the 
hypolipidemic effect of this plant. The hypolipidemic effect may be due to inhibition of 
fatty acid synthesis (Sharma et al., 2003). In normal metabolism insulin activates the 
enzyme lipoprotein lipase and hydrolyses triglycerides and the deficiency in insulin 
results in inactivation of these enzymes thereby causing hypertriglyceridemia. The 
significant reduction of serum lipid levels in diabetic rats after treatment with extracts of 
Eremurus himalaicus may be directly attributed to improvements in insulin levels. 
Phytochemical analysis of the various extracts of Eremurus himalaicus revealed 
the presence of secondary metabolites that have been shown to possess antidiabetic effect 
in other plants (Marles and Fransworth, 1995; Saxena et al., 2004). Saponins (Abdel –
Zaher et al., 2005), alkaloids (Li et al., 2004) and flavonoids (Coskul et al., 2005; 
Tanko et al., 2007) which were responsible for the antidiabetic effect in other plants 
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were also detected in the extracts of this plant. The presence of phenols in the plant could 
also be responsible for the antidiabetic effect as phenols have antioxidant effect and 
antioxidants have been shown to prevent the destruction of β-cells by inhibiting the 
peroxidation chain reaction and thus they may provide protection against the 
development of diabetes (Alexandru et al., 2001; Ruan et al., 2008; Patel et al., 2011). 
Extracts of Eremurus himalaicus appear to be attractive materials for further 
studies leading to possible drug development for diabetes. Development of 
phytomedicines is relatively inexpensive and less time consuming; it is more suited to our 
economic conditions than allopathic drug development which is more expensive and 
spread over several years. 
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The study was performed to find out the beneficial effects of different extracts of 
Eremurus himalaicus plant in normoglycaemic rats and alloxan induced diabetic rats and 
the results reveal that the plant has beneficial effects on blood glucose levels of normal as 
well as alloxan induced diabetic rats and the results also reveal that the plant extracts 
significantly protect from other metabolic aberrations found in diabetes, physiological as 
well as biochemical aberrations.  
The results indicate that the ethyl acetate extract is most potent in lowering the 
fasting blood glucose level of the diabetic rats followed by aqueous and methanol 
extracts; the effect is dose dependent. Moreover, the extracts show improvement in 
parameters like body weight, food intake, fluid intake and urine excreted. The extracts 
also lower serum SGPT, SGOT, and ALP levels which show the effect of the extracts in 
reversing the organ damage due to diabetes which is clearly observed by high levels of 
SGOT and SGPT in diabetic control. The extracts also lower the levels of serum lipids 
like triglycerides and cholesterol. Histopathological examination of pancreas show the 
recovery of damaged tissue when sections of treated groups are compared with diabetic 
control. From the toxicity studies it was concluded that the extracts are safe and don’t 
show any sort of toxic reactions up to the oral doses of 2000 mg/kg of body weight. 
The extracts also show increase in the glucose tolerance of the rats and decrease 
in the fasting blood glucose level of normal rats, showing the hypoglycaemic activity of 
the plant which is most pronounced in aqueous extract. 
Result from the phytochemical analysis of Eremurus himalaicus revealed the 
presence of alkaloids, tannins, saponins, terpenoids, flavonoids, phenolics and glycosides 
as the possible biologically active principles, which have also been isolated from the 
other plants and found to possess antidiabetic activity. 
In nutshell the extracts of Eremurus himalaicus possesses significant 
hypoglycaemic and antidiabetic activity, which is the first claim in this respect. 
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